• 検索結果がありません。

Alternaria alternata ļ ļżƑhǬʯʓʘˁ

N/A
N/A
Protected

Academic year: 2021

シェア "Alternaria alternata ļ ļżƑhǬʯʓʘˁ"

Copied!
105
0
0

読み込み中.... (全文を見る)

全文

(1)

Alternaria alternata ļ ļżƑhǬʯʓʘˁ

Ņǝ˗˯̀˔˞˅“ƗʬʝʤƑhèƒƃŅŀʰȌİ

(Studies on molecular mechanisms of pathogenicity of Alternaria alternata plant pathogens based on functional genomics)

ɻ»ɿ ~¬

Kazumi Takao

(2016)

(2)

1 ƘƘɿ Ň

Ƶ1Ƴɿ ǑtÏȟ ---2

Ƶ2Ƴɿ ĬėʓʾʳĚŘ --- 4

Ƶ3Ƴɿ ǫĵƑǬʯʓʘˁƑhèɗȼɇ ¥ʰĄDž --- 26

ɿ Ƶ1ƹɿ Ïȟ --- 26

ɿ Ƶ2ƹɿ ĬėʓʾʳĚŘ --- 29

ɿ Ƶ3ƹɿ NJij --- 31

ɿ Ƶ4ƹɿ Ǚ³ --- 66

Ƶ4Ƴɿɿ °ŽƏƕAALŏDŽƇtñɇ ¥˔̈˞ˣ̐ʰ ɿ ɿ ɿ ɿ ɿ ɿ ɿ ɨƑhèA. alternataǬʴʰ·> --- 72

ɿ Ƶ1ƹɿ Ïȟ --- 72

ɿ Ƶ2ƹɿ ĬėʓʾʳĚŘ --- 74

ɿ Ƶ3ƹɿ NJij --- 76

ɿ Ƶ4ƹɿ Ǚ³ --- 88

Ƶ5Ƴɿ Ċȅ ---90

Ƶ6Ƴɿ Summury ---92

Ƶ7Ƴɿ ÔƉĕſ ---94

¨ȗ@ǽȟĕ̉˞˪ ---104

(3)

2 Ƶ

Ƶ1Ƴɿ ǑtÏȟ

ɿ ƍoʰ—ZʽęǦ‹ʰɵʰ›_ʯ!ʐʊɵƾʰƢ.ʱs‹ʰƒǐʰȝɱʬ ʮˀʨʨʏˁʋʚʰ‚ɱ˅ȌŖʟˁʤʻʊ©«ʝʤ)żƇƈʕȅŕʜ˂ʪʐˁʋĚʊ

²řʽËʲʨʮʭʰŒ3›_ʽƑ®ǴʯʾˁǾ®ʯʾˀʊʗʰ)żʱŨl˅(9 ʮʗʜ˂ʪʐˁʋʚ˂ʿǾ®˅ĥ¸əʯɵʐňʻˁʤʻʊļżʯŁʌʮù÷èʕ ʜ˂ʪʐˁʋʝʔʝʮʕʿʊʚ˂ʿù÷èʰʑʦƇżʯ´ʟˁʼʰʱʊ´ȤƇżʰ

›Əʯʾˀôơʜ˂ˁqǝèʕʏˁʋ

ɿ ļżʰƑŒʰ80%˅eʻˁǬɳʱʊƃʸʫʯ 10ƭʕ”zʜ˂ʪʓ ˀʊʢʰʑʦʰǁ 7,000 ƭʕʊļżƑhǬʬʝʪ”zʜ˂ʪʐˁʋʚʰʾʑʯēʗʰ ƑhǬʕKɡʊu«ʜ˂ʪʐˁʕʊʢ˂ʿʰʗʱƑhèƒƃŅŀʯʨʐʪȖdžʕ ĝʿʔʬʮʧʪʐʮʐʋĚʊļżʴʰù÷èʰʽęȈȲDzʰɕƒ˅ǹʑ•tʊ ƑhèǬʬɨƑhèǬʬʰɄʐʽʊƑhèʰȾ_ʊƀÞʊţ¢ʮʭǬʰé”ʰ ʫʼʊʬˀ˄ʘƑhèƒƃŅŀʯɗʟˁé”ʕäȅʯʮˁʚʬʱȍʑʸʫʼʮʐʋ ɿ ȵÍʊ˜̐˔ˍ̎˞öǺʰǯʝʐƒ½ʯʾˀʊʗʰƇżƭʰ˗˯́é”ʕDZƮʜ

˂ʨʨʏˁʋ˳˪ʽļżʯŐʵʊ˗˯́˚ˊ˟ʰ¸ʜʐǬɳʱʊ˫̈˶˪Ȍİ˅xʻˁ ʬʊÍɖē`ʰ˗˯́é”ʕ@ɕʜ˂ʪʓˀʊʚ˂ʿ˅QƉʝʤƑhèɇ ¥ʰĄDž ʮʭʼǹ˄˂ʨʨʏˁʋʚʰʾʑʯʊ˘̎˵̅̐ˣ̐ʫžɑʰ˗˯́é”ʔʿ3ȁʬ ʮˁƑhèɇ ¥˅ȇJʟʚʬʕ¯ĞʯʮˁĚʫʊ¬ɞʯʢʰ3ȁɇ ¥ʰŅ ǝ˅u«ʟˁʤʻʯʱʊɇ ¥ơ™ʽɇ ¥˚ˊ̋̎˜̎˕ŘʯʾˀŅǝȌİ˅ǹ ʑäȅʕʏˁʋʢʰʤʻʊ˗˯̀˔˞Ơư˺̐˞ʫʗʰƑhè3ȁɇ ¥ʱĆ«ʜ

˂ˁʼʰʰʊ¬ɞʰŅǝʱĝʫʏˁ•tʕʐʋ

ɿ Alternaria alternata ʱƍ ʯKÆʟˁǬʫʏˀʊ“īƕʯǟèƇŝ˅ȷʧʪʐ ˁ (Rotem 1994)ʋʢʰ ʫʊ°ŽƏƕŏDŽ (host-specific toxinʊʊHST) Ƈ ƈǝ˅ƀÞʝʤʼʰʰʹʕʊƑhǬʬʮˁʋʚ˂ʸʫʯʊ¹ʮʗʬʼ7ƭʰƑhʕ§

ʟˁʚʬʕĝʿʔʬʮʧʪʐˁ (Kohmoto et al. 1995, Thomma 2003)ʋȵÍʊʚ˂ʿ HSTʰƇtñʯɗ˄ˁɇ ¥ʕȇJʜ˂ʊʢʰƇtñɇ ¥ʕ˔̈˞ˣ̐_ʝʪʐ ˁʚʬʼ”zʜ˂ʪʐˁ (Akagi et al. 2005, Akamatsu et al. 2003, Harimoto et al. 2007, Hatta et al. 2002, Johnson et al. 2001, Miyamoto et al. 2009)ʋʜʿʯƑhèʯäɮʫ ʏˁʚ˂ʿ HST Ƈtñɇ ¥ʱʊ¹ʮʗʬʼˊ˥˙ʊ̉̎˙ʊ˪˿˪Ƒhʯʓʐʪ conditionally dispensable chromosome (CDC) (Covert 1998) ʬ|ʲ˂ˁ1.8 Mb ʰĶǩ&ʯÑʝʪʐˁʚʬʕĝʿʔʬʮʧʪʐˁ (Akagi et al. 2009, Akamatsu et al. 2003, Hatta et al. 2002, Harimoto et al. 2007, Johnson et al. 2001)ʋ

ɿ īƠưʫʱʊHSTƇƈA. alternataƑhǬ˅´Ȥʬʝʪʊˮ˔̌˪̌˶ļżƑhǬʯ

(4)

3

ʓʘˁƑhèɇ ¥˅˗˯́é”ʯ“ʩʖŅǝȌİʝʊʢʰƑhèƒƃŅŀ˅^

ýƕʯȌĝʟˁʚʬ˅ƘĀʝʤʋƑhèɗȼɇ ¥ʬʝʪʊŏDŽƇtñɇ ¥ʊ˜

˕ˬ̉̎˕ɗȼɇ ¥ʓʾʳˍ˵˝ˌˮ˨ˉ˦˔Rßʯɗ˄ˁ˕̌̐˱̊̋˓̅̋̐

ˣ̐ɇ ¥˅ʮȌİ´Ȥʬʝʤʋ

ɿ ¨$ȟĕĈJʯʏʤˀʊʛĀ·ʊʛbXɫʖʸʝʤʊĀ·Ē€ʰɼmž¨ž¨

ɚȼtȲ¨ƠưƨļżƑƅ¨Ơư­ɿ =Ƃ“ħĒĂʊvp¼ž¨ɿ ķļºå ĒĂʊÁÀž¨ɿ ÀīÎdGĒĂʊɼmž¨ļżƑƅ¨Ơư­ɿ ȪĨɦCdšʊ ȪĨƛǗőʮʿʳʯƠư­Ƞőʊʸʤʊɼmž¨ɿ TàɉĒĂʊƟhɿ ĒĂʊ Àož¨ɿ dzƛĒĂʊʓʾʳÂ垨ɿ ɐɿ țGĒĂʯgʗßƤƋʝʙʸ ʟʋ

(5)

4 Ƶ

Ƶ 2Ƴɿ ĬėʓʾʳĚŘ

ɿ ʚʰƳʫʱʊɘʰ¬ɹʫ*Ɖʜ˂ˁAȹʰĬėʬĚŘ˅ȑʝʤʋ

1. +ȔǬʓʾʳ+Ȕļż

+ȔǬʬʝʪʊ*ƉʝʤǬĸʰ̉˞˪ʱǽ 2 ʯƣʝʤʋǬĸʱ˝̄ˑˊ̃²Ÿ

(PDA) ’Žʫ’ɷʝʤʋǬĸʰ.§ʱ˃ǃʯʾˁ.§ʬ˕̉ˠ̌̐̊ʯʾˁ.§ʰ 2

ƭɳʰĚŘʫǹʧʤʋ

̏˃ǃʯʾˁ.§: ǁ1 cmȋʯLʧʤ˃ǃ (Whatman, 3MM CHR̓ ˅ēIJʊ’Žʰ ¡ʔʿɡʝʪʰʡʤÜʊǬ&˅’Ž ¡ʯļǬʝʤʋǬ&ʕ˃ǃʯ"ʳʤŌɜ ʫ’ŽʔʿÔʖʱʕʝʊ˔̉̐̎˺̎˥ ʫɴÜʊ5ʀ5 cm ʰ¸µƷʯ>˂

-20ʇʫ.§ʝʤʋ

̏˕̉ˠ̌̐̊ʯʾˁ.§: ’ŽʫñɔʝʤǬ&˅5 mmȋʯLˀmˀʊ20%˕̉ˠ̌

̐̊ʰ>ʧʤˍ˦˻̎˫̊˶˥̅̐˷ʯƫʝʊ-80ʇʫ.§ʝʤʋ

ɿ +ȔļżʱǫĵƑǬʯínèʫʏˁ˪˿˪ (Solanum lycopersicum) ƭʊìƝ˶

ˇ̐˞˪˅Ɖʐʤʋ

2. ȔDzʓʾʳ’Ž

īƠưʫ*ƉʝʤȔDzʓʾʳ’ŽʰsLjñʱǽ3ʯƣʝʤʋ

3. ˗˯́ DNAʰúJ

ɿ sǬʔʿʰ˗˯́ DNA ʰúJʓʾʳ.§ʱȪĨ (ȪĨ 2010) ʰĚŘ 3 ƭ (Yoder ʿ (Yoder et al. 1994) ʰ Miniprep Ř˅đ›ʝʤ Miniprep ŘʊSuzuki ʿ (Suzuki et al. 2006) ʰĚŘ˅đ›ʝʤɣ¥̋̎˝ƼĞúJŘʓʾʳŤ&ƱDŽƼĞ úJŘʊʊǽȑ˅ʢ˂ʣ˂MiniprepŘʊɣ¥̋̎˝ŘʓʾʳŤ&ƱDŽŘʬʟˁ) ʯÝʐǹʧʤʋ

4. ? RNAʰúJ

4-1. RNeasy plant kit˅Ɖʐʤ RNAʰúJ

Ǭ&˅ PDAʯļǬʝʊ3 ĜƬÐñɔʜʡʤÜʊ›ŘRichards Ť&’Žʯ 5 mm ȋŻ˅201ƬÐļǬʝʤʋēĜɖāʬʑ’ɷ (120 rpm) ÜʊyÔŴɁʝʊǬ&˅…

lʝʤʋʚʰÜʰĎ)ʱRNeasy plant kit (Qiagen) ʰ˸̌˪˘̊ʯÝʐǹʧʤʋÞʿ

˂ʤRNAʯxʸ˂ˁDNAʱDNaseʈʫIƅÜʊ˶ˌ˯̐̊/˔̌̌˼̊́úJʫɛ iʓʾʳǂ_ʝʤʋÞʿ˂ʤRNAʱPCRʯʾˀʊDNAʰ˘̎ˣ̀ˮ̐˜̇̎ʰĦŶ˅

ƢȘʝʤʋʢʰÜʊGeneQuant pro RNA/DNA Calculator (Amersham pharmacia biotechʊƃGE˹̊˞˖ˈ) ʫųÐʬǂÐ˅ū«ʝʤʋ

(6)

5

ǽ1 ALT˔̈˞ˣ̐ɇ ¥ʰAALŏDŽƇƈʬĆ«Ņǝ

(7)

6 ǽ2ɿ īƠưʫ*ƉʝʤǬĸ

Ǭĸ ƭv ° ăɠŽ

As-27 A. alternata ˪˿˪ ˈ̂̉ː

O-94 A. alternata ĩu« Ĝīʊɼm

O-276 A. alternata ˭˼̎ˬ˜ Ĝīʊɼm

AC320 A. alternata ˣ̎ˡ̉̎ ˈ̂̉ː

AC325 A. alternata ̈˶̋̃̎ ˈ̂̉ː

NAF8 A. alternata ˊ˥˙ ĜīʊìƝ

M-30 A. alternata ˊ˥˙ Ĝīʊɼm

M-71 A. alternata ̉̎˙ Ĝīʊɔɐ

IFO8984 A. alternata ̉̎˙ ĜīʊBÒ

(8)

7

ǽ3ɿ īƠưʫ*ƉʝʤȔDzʓʾʳ’ŽʰLjñ

LB medium 1 l

Tryptone peptone 10 g

Yeast extract 5 g

NaCl 10 g

Agar powder 15 g

Regeneration medium 1 l

1 M Sucrose 342.3 g

0.1 % Casein hydrolysate enzymatic 1 g 0.1 % Yeast extract 1 g

Crossing medium 1 l

Ca(NO3)2̏4H2O 1 g

K2HPO4̏3H2O 0.25 g

MgSO4̏7H2O 0.25 g

CaCO3 0.85 g

Agar 20 g

PDA medium 1 l

potato 200 g

glucose 20 g

agar 15 g

PDB medium 1 l

potato 200 g

glucose 20 g

V8 medium 1 l

V8 juice 200 ml

CaCO3 3 g

agar ɿ 15 g

(9)

8

ǎʖ ɿ ɿ

Buffer1 (pH 7.5) 3 l

0.1 M Maleic acid 29.42 g

0.15 M NaCl 26.3 g

Buffer2 200 ml

Blocking reagent 2 g

Buffer1 200 ml

Buffer3 (pH 9.5) 200 ml

0.1 M Tris-Cl 2.42 g

0.1 M NaCl 1.16 g

50 mM MgCl2̏6H2O 2.03 g

Buffer4 1 l

10 mM Tris-Cl (pH 8.0) 10 ml (1 M Tris-Cl) 1.0 mM EDTA (pH 8.0) 1 ml (1 M EDTA)

20xSSC (pH 7.0) 1 l

3 M NaCl 175.32 g

0.3 M Na-citrate 88.23 g

Transfer buffer 2 l

0.4 M NaOH 32 g

1.5 M NaCl 174 g

Probe stripping buffer 1 l

0.2 M NaOH 8 g

0.1 % SDS 10 ml (10 % SDS)

Neutralizing buffer (pH 7.2) 1 l

0.5 M Tris-Cl 60.5 g

1.0 M NaCl ɿ 58 g

(10)

9 ǎʖ

Richards medium (reviced) ɿ 1 l

KNO3 10 g

KH2PO4 5 g

MgSO4̏7H2O 2.5 g

FeCl3 0.02 g

glucose 25 g

Yeast extract 1 g

OM buffer (pH 5.8) 1 l

1.2 M MgSO4̏7H2O 296 g

10 mM Na2HPO4 100 ml (100 mM Na2HPO4) pH 5.8 with NaH2PO4̏2H2O

ST buffer 100 ml

1.0 M Sorbitol 18.2 g

0.1 M Tris-Cl (pH 8.0) 10 ml (1 M Tris-Cl)

STC buffer 500 ml

1.0 M Sorbitol 91 g

50 mM Tris-Cl (pH 8.0) 25 ml

50 mM CaCl2̏2H2O 3.65 g

0.5xTBE 2, 3 l

0.45 mM Tris-Cl 10.8, 16.2 g 0.45 mM Boric acid 5.5, 8.25 g

1.0 mM EDTA 0.75, 1.125 g

Hybridization buffer 200 ml

5xSSC 50 ml (20×SSC)

1 % Blocking reagent 2 g

0.1 % SLS 2 ml (10 % SLS)

0.02 % SDS 400 μl (10 % SDS)

(11)

10

ǎʖ ɿ

Solution I 100 ml

50 mM glucose 0.9 g

25 mM Tris-Cl (pH 8.0) 2.5 ml (1 M Tris-Cl) 10 mM EDTA (pH 8.0) 1 ml (1 M EDTA)

Solution II 100 ml

0.2 M NaOH 0.8 g

1 % SDS 10 ml (10 % SDS)

Solution III 100 ml

3 M potassium acetate 29.45 g

acetic acid 11.5 ml (Add after autclaved)

TE buffer 100 ml

10 mM Tris-Cl (pH 7.5) 1 ml (1 M Tris-Cl) 1 mM EDTA (pH 8.0) 0.1 ml (1 M EDTA)

1xBromophenol Blue (BPB) 10 ml

0.25% BPB 25 mg

30% glycerol 3 ml

Yoder's buffer 100 ml

100 mM LiCl 10 ml (1 M LiCl) 10 mM EDTA (pH 8.0) 1 ml (1 M EDTA) 10 mM Tris-Cl (pH 7.4) 1 ml (1 M Tris-Cl)

0.5 % SDS 0.5 g

x % PEG 100 ml

50 mM CaCl2̏2H2O 0.73 g

50 mM Tris-Cl (pH 8.0) 5 ml (1 M Tris-Cl)

1 M Sorbitol 18.2 g

PEG4000 ɿ x g

(12)

11 4-2. ȸȸȯFkæ

ȸȯFkæʱʊPrimeScript RT reagent Kit (Takara Bio) ŦʰȜĝģʯÝʐǹ ʧʤʋȑ4-1ʫÞʤRNAʱȪĨ (ȪĨ 2010) ʰĚŘʫkæŤ˅ȞȂʝʤʋÞʿ

˂ʤʊcDNAʱƒƃȌİʰ˨̎˸̋̐˪ʬʝʪɘʰ¬ɹʯ*Ɖʝʤʋ

5. ɇ ¥ʰƒƃȌİ

5-1. Reverse transcription PCR (RT-PCR)

ɿ ɇ ¥ʰƒƃ˅ƢȘʟˁʤʻʊĽ«ʟˁǬĸʰRNAʱTȶʰĚŘʫúJʓʾʳ ȸȯFʝʤʋÞʿ˂ʤ cDNA ˅˨̎˸̋̐˪ʬʝʊëʰ˸̈ˊ˿̐˅*ƉʝʊRTʉ PCR ˅ǹʧʤʋPCR ÜʊɣŒś]˅ǹʐʊƘƕʰ˱̎˫˅ƢȘʟˁʚʬʫƒƃʰĦ Ŷ˅Ľȏʝʤʋ

5-2. ˊ̎ˣ̐ː̋̐˪Řʯʾˁ Real-time PCR

sɇ ¥ʰƒƃ˅«ɑʟˁʤʻʯʊReal-time PCR (Roche, Light Cycler 480) ˅ǹ ʧʤʋPCR ʰɞʰ mixture ʱǶ<ǩDŽ SYBR Green I (Roche, Light Cycler 480 SYBR Green I Master) ʰȜĝģʯÝʐ)ñʝʤʋcDNAʱȑ4-2ʰʬʓˀkæɑ

˅20 μlʬʮˁʾʑʯʝʊRNAʕ0.8 μgʯʮˁʾʑZʒtñʝʤʋȸȯFÜʊmilliQ˅ Zʒ100 μlʯ̂˞ˈ˦˸ʝʤʋ

ɿ SYBR Green Iʰ˒˦˪ʯ¾ʝʪʐˁwater 4 μlʊPCR primer 2 μlʊmaster mix 9 μl

˅˥̅̐˷ʯ>˂ʊ˵˻˦˨ˉ̎˕ʯʾˀťtʝʊLight Cycler 480 Multiwell Plate 96 ʯ15 μlʠʨZʒʤʋʢʰÜʊ˨̎˸̋̐˪ʫʏˁcDNA˅5 μlʠʨZʒʤʋkæʱ Ȝĝģʰ˸̌˪˘̊ʯÝʐʊƒƃɑʱī&¾ʰˢ˶˪ˋˌˈʫ«ɑʝʤʋ˸̈ˊ˿

̐ʰųÐʱ10 µMʬʝʤʋ˸̈ˊ˿̐ʱǽ7ʯƣʝʤʋ

6. PCR

ɿ PCR (ˣː̈˱ˊˏ, TP650 ʓʾʳ TP350̏˱ˊˏ̈˦˫, 170-9703JȀeppendorf, 95004) ʯʾˁDNAʰ—ÊʱʊsƭTaqʛʬʯŦʜ˂ʪʐˁ˸̌˪˘̊ʯÝʐǹʧ ʤʋ˸̈ˊ˿̐ʰųÐʱ10ʏˁʐʱ20 µMʯȞȂʝʤʋsƭTaqʛʬʰPCRğʰ Ljñʱǽ5ʯʊPCRʯ*Ɖʜ˂ʤ?˸̈ˊ˿̐ʱǽ4ʯƣʝʤʋ

7. ɣŒś]

ɿ Agarose S ʓʾʳAgarose HSʯ0.5xTBE buffer ˅Zʒʊɣ¥̋̎˝ʫŮȌʝʤ (ųÐʱƈż˚ˊ˟ʯ,§)ʋŮʘʤ˗̊˅ĴʯŞʝŠʻʊ0.5xTBE buffer ʫŭʤʝ ʤś]łʯ˗̊˅>˂ʊɣŒś] (Mupid-exu) ˅ǹʧʤʋ

(13)

12 ǽ4ɿ īƠưʫƉʐʤ˸̈ˊ˿̐

˸̈ˊ˿̐ ɋM TM4

ALT10AF gcgctaaccgcagtgtgact 67.6

ALT10AR-SfiA cacggcctatatggcccagagccgtccttgacat 69.3

ALT10BR ctgcctctgataccgactca 63.0

ALT10BF-SfiB gtgggccacgcaggccagtgagatggcacccgac 74.1 Hph-SfiA-1-ra cacggccatataggccttacactttatgcttccg 77.3 Hph-SfiB-1-ra gtgggcctgcgtggcccttcgctattacgcca 71.2

hph-F acgtctgtcgagaagtttc 59.0

hph-F2 gacgtctgtcgagaagtttctg 62.9

hph-R gtattgaccgattccttgcg 64.2

ALT10inF tgcacatagcaatcatccg 63.2

ALT10inR gtggcatggagtctttggtg 65.5

ALT10homoF agatcactcgttgctgcttg 63.2

HphA-homoR cagagattacttcaagtcag 68.3

HphB-homoF ttacaacgtcgtgactggga 64.2

ALT10-wholeF atgacggccaacgtaaacgtc 67.9 ALT10-wholeR ctaactgcaacggaacaaggac 64.6 npt-F gacaatcggctgctctgatg

npt-R atgcgatgtttcgcttggtg

ALT5AF1 ggcaggcagtatagatcagaatctcc 67.6

ALT5FuAR1 atcaggtcgatgctagcatcagcaaaatctcccacatacg 81.7 ALT5FuBF1 atgcgagtgctaccagatgtcggaaggcgtagctatagtc 80.5

ALT5BR1 gccatggcagtcgaaactctgtatgc 73.7

ALT5inF ttgtaggtcctgtgggttcg 67.8

ALT5inR tgagggcccaaagatgtggc 71.5

ALT6FuAF ggaagactgggttggtgaag 63.5

ALT6FuAR20 atcaggtcgatgctagcatctaacgcaggccctgaatgag 83.4 ALT6FuBF20 atgcgagtgctaccagatgtcattgcttaaggctgaggag 81.5

ALT6FuBR caagcacggacactctagct 62.2

ALT6inF aactccctctgtccttcgag 62.3

ALT6inR tctccgggtgacttggccag 71.9

TF1AF cggcaaagcgtcgtcgtgttgttgc 79.7

TF1FuAR atcaggtcgatgctagcatcggcttaccacatgtctcaga 82.7 TRF1BF1 atgcgagtgctaccagatgtaccggagacgccaagacgac 85.4

TRF1BR1 gatgcgacgctgcaaccgcagaagg 80.7

(14)

13 ǎʖ

TF1inF ccactggtcgagaagggtac 63.5

TF1inR gacctctgcctgcgatggac 69.5

TF1homoF gatcgctcacctgggtagac 63.6

TF2AF gcacgatccctgcacggataaggac 75.5

TF2FuAR atcaggtcgatgctagcatcgttgcaggccaagttgagct 85.0 TF2FuBF atgcgagtgctaccagatgttaagaggcatccagtccgac 82.6

TF2BR catgcgaccatgatcccttggcctctc 79.2

TF2inF tatgctcgcagccttcatcg 68.5

TF2inR acaaggacgcgttatcgtcg 67.1

TF2homoF gcgtttatcccggaactgtc 65.4

TF3AF ctcgaacatgtctcgcatgatgatcag 73.2

TF3FuAR atcaggtcgatgctagcatcctagcatccttgacccacgc 84.5 TF3FuBF atgcgagtgctaccagatgttatggtctgagcagccattg 82.7

TF3BR ctactacgtgcagcagatcctagcaac 68.5

TF3inF tctgtctgttccactggtgc 64.1

TF3inR cagatcgtactggaagcacg 63.4

TF3homoF gacctgcctcctgcagcaac 69.6

TF4AF caatggcagtcgccttactcgagac 72.3

TF4FuAR atcaggtcgatgctagcatcccttaacacagcacataacg 80.5 TF4FuBF atgcgagtgctaccagatgtgtagtccaggatctgcacgg 84.2

TF4BR gatgtcgggaaatacaagcacatgtg 70.7

TF4inF tctagagatgccggaaggcg 68.6

TF4inR cgaacggggttacattcgag 66.3

TF4homoF gattgcctgctggcgaccag 72.4

Ave1AFL aaggcgcagactgaggggat 69.3

Ave1ARL atcaggtcgatgctagcatcccggacatgtctgccatctg 86.2 Ave1BFL atcaggtcgatgctagcatcgcttgttaccgtcctccagc 81.8

Ave1BRL tggtaggggcatattgccga 70.9

Ave1inFL acttcatgcggacacgatgc 67.6

Ave1inRL ccgtcctccagctccagaag 65.8

Ave1homoF gcgatgctagaggctttgtc 63.9

LAE1AF ggtactcgtctcgcgtaagc 63.8

LAE1AR atcaggtcgatgctagcatcgcagcgcaggccattaacag 86.3 LAE1BF atgcgagtgctaccagatgtgtaccacgcgactacgagag 83.0

LAE1BR gtgacaggcagactcccttg 64.9

(15)

14 ǎʖ

LAE1inF catgtacccgtgcgacgagg 70.9

LAE1inR gagatccaatcccagcacct 65.3

LAE1homoF gtgctcttacaacgctgcag 63.7

Lae1comR ctgctgccatgccattgccg 76.1

AGAt1AF caggctagcactagcagcag 63.0

AGAt1AR atcaggtcgatgctagcatcgtacgtagtgatgttccgtc 80.9 AGAt1BF atgcgagtgctaccagatgtctccgagtatgaccagctgc 83.7

AGAt1BR gttgggttgagttggaaccg 66.5

AGAt1inF ggagggcaagcagaggaacg 70.4

AGAt1inR gtgctggctgcatgaagatg 67.0

AGAt1homoF gtgatgctagtcgtcgcaag 63.6

STE2AF cgattcgttgcgactgccgc 75.2

STE2AR atcaggtcgatgctagcatcgattgcttgggatagcggtg 84.7 STE2BF atgcgagtgctaccagatgtaacggctgatcaggagcgac 84.4

STE2BR gcgaagtggttgtagcagag 62.6

STE2inF ctgtcatggcctgcattgcg 72.2

STE2inR tggtcgttgacgacgccagc 74.2

STE2homoF ctggtgagctaacggtgacg 65.8

STE2homoR ccagatagaactgagtgcag 57.5

GPCR1-AF-re gtagtgctacagtagtaccacgaggtag 63.1 GPCR1-AR20 atcaggtcgatgctagcatccctgagctgaaccaaaactc 82.1 GPCR1-BF20 atgcgagtgctaccagatgtgagtaggtaatgcgctgaga 81.4

GPCR1-BR gacgcgatacgccatagtct 64.0

GPCR1-inF ggtagccggtaacaatgtag 58.6

GPCR1-inR cctatgcgagcttcagggac 66.0

GPCR1-homoF gacatgaaccacacagttgg 61.5

GPCR2AF gtgttgacgggccctctcag 69.0

GRCE2AR atcaggtcgatgctagcatcccaaggatgaaaacccagag 67.9 GRCR2BF atgcgagtgctaccagatgtcaacaagggtcatcagcgag 68.9

GPCR2BR gtatgtcgcgctatggcggc 71.6

GPCR2inF cgcttgctcgtctttgcctc 69.4

GPCR2inR gatcgtcgaccccttgtgtg 67.9

GPCRhomoF cgctcttgtcctctccccag 68.5

GPCR3AF ggcctgactcttggtccatg 67.0

GPCR3AR atcaggtcgatgctagcatccagaactgtcaccgcaacgc 70.0

(16)

15 ǎʖ

GPCR3BF atgcgagtgctaccagatgtcaacgagaagagccaaatcg 67.9

GPCR3BR cataccccaacctgtggatc 64.0

GPCR3inF gtgtgagcttgctagtgtcg 61.0

GPCR3inR caggagcgatatttcgctcg 66.8

GPCRhomoF acatgtcaaaggagctgcgg 67.5

GPCR3comF caacactcccctgattaccc 63.1

GPCR3comR cgcacatcagcacggcgag 73.9

HPHA20-fusion gatgctagcatcgacctgatttacactttatgcttccg 77.6 HPHB20-fusion acatctggtagcactcgcatcttcgctattacgcca 80.3

Btub1 tccgtcgtgccttcccccaaggtctccgac 85.2

Btub2 ggagcgaatccgaccatgaagaagtggaga 78.7

(17)

16 ǽ5ɿ PCRkæŤʰLjñ

KOD FX (TOYOBO) µl µl

2x PCR buffer for KOD FX 25 10

2 mM dNTPs 10 4

Primer F (10 µM) 1 0.4

Primer R (10 µM) 1 0.4

KOD plus (1 U/µl) 1 0.4

Sample DNA x x

MilliQ 12-x 4.8-x

Total 50 20

EX Taq (TOYOBO) µl µl

10x EX buffer 5 2

2.5 mM dNTPs 4 1.6

Primer F (10 µM) 1 1

Primer R (10 µM) 1 1

EX Taq (5 U/µl) 0.25 0.1

Sample DNA x x

MilliQ 38.75-x 14.3-x

Total 50 20

LA Taq (TAKARA) µl µl

10x LA buffer 5 2

2.5 mM dNTPs 8 3.2

25 mM MgCl2 5 2

Primer F (10 µM) 1 1

Primer R (10 µM) 1 1

LA Taq (5 U/µl) 0.5 0.2

Sample DNA x x

MilliQ 29.5-x 10.6-x

Total 50 20

(18)

17

ǎʖ ɿ ɿ

rTaq (TOYOBO) µl

10x buffer 2

2 mM dNTPs 2

Primer F (10 µM) 1

Primer R (10 µM) 1

Recombinant Taq (5 U/µl) 0.1-0.2

Sample DNA X

MilliQ 13.9 or 13.8-x

Total 20

2x Quick Taq HS DyeMix (TOYOBO) µl

2x Quick Taq HS DyeMix 25

Primer F (10 µM) 1

Primer R (10 µM) 1

MilliQ 23-x

Sample DNA x

Total 50

ɿ

(19)

18 8. ˗˗̊úJ

ɿ Ƙƕʰ˱̎˫˅ɣŒś]ʯʪKɡÜʊEtBr ʫĶǩʊǰƎœʫǞǩʝʊUV ̈̎˸

(300 nm) Ÿ¶ʫʊƘƕʬʟˁ˱̎˫˅LˀJʝʤʋ˗̊˅1.5 mlˍ˦˻̎˫̊˶˥

̅̐˷ʴƫʝʊQIAquick Gel Extraction Kit (Qiagen) Ŧʰ˿˭̅ˈ̊ʯƣʜ˂ʤ óɭʯÝʐ˗̊ʔʿDNAʰúJ˅ǹʧʤʋ

9. fusion PCRŘ˅Ɖʐʤɇ ¥˯˦˔ˈˋ˪ (KO) ˺˔ˣ̐ʰŀƻ

ɿ ˺˔ˣ̐ʰŀƻʱʊ ıʿ ( ı 2010) ʰĚŘ˅đ›ʝʊǹʧʤʋʸʠʊĘŻAʰ 3’5˸̈ˊ˿̐ʯëʰ–“ɋMʊ20 mer˅Zʝʤ˸̈ˊ˿̐˅ƉʐʊĘŻA˅—

ÊʝʤʋŇʯʊĘŻBʰ5’5˸̈ˊ˿̐ʯ;ʶʭʬʱƏʮˁëʰ–“ɋMʊ20 mer

˅Zʜʡʤ˸̈ˊ˿̐˅ƉʐʊĘŻB˅—Êʝʤʋʸʤʊ5’5˸̈ˊ˿̐ʯĘŻAʫ Ɖʐʤëʰ20 merʰƚȁɋM˅Zʝʊ3’5˸̈ˊ˿̐ʯĘŻBʫƉʐʤëʰ 20 merʰƚȁɋM˅Zʜʡʤʋʚ˂ʿʰ˸̈ˊ˿̐˻ˈ˅Ɖʐʪhphːˠ˦˪˅—

ÊʝʤʋĘŻAʓʾʳB˅—ÊʟˁɞʱEX Taq˅Ɖʐʪtotal 20 μlʫǹʐʊhphːˠ˦

˪˅—ÊʟˁɞʱʊKOD FX˅Ɖʐʪtotal 20 μlʫǹʧʤʋʚ˂ʿ3ʨʰPCRƈżs1 μl˅˨̎˸̋̐˪ʯĘŻAʰ5’5˸̈ˊ˿̐ʊĘŻBʰ3’5˸̈ˊ˿̐˅Ɖʐʪǽ6ʫ ƣʝʤĮʫfusion PCR˅ǹʐʊƘƕʰ˚ˊ˟˅˗̊úJÜʊKO˺˔ˣ̐ʬʝʤʋ

10. ˸̌˪˸̈˞˪ʰcɡ

˸̌˪˸̈˞˪ʰcɡʱʊYeltonʿʰĚŘ˅đ›ʝʤAkamatsuʿʰĚŘʯÝʐǹʧ ʤ (Akamatsu et al. 1997, Tsuge et al. 1990, Yelton et al. 1984)ʋPDAʫ’ɷʝʤ sǬĸ˅1 mmȋʯLˀʊǁ20ĘŻ˅50 mlʰPDBʯļǬʝʊ25ʇʫ36 hʊāʬʑ

’ɷ (ˣˊ˨˦˔, Bio-Shaker BR-300L, 100 strokes/min) ʝʤʋÞʿ˂ʤǬƿ˅ůǬ œʊOM bufferʰɭʯŜşʝʤʋ5 mlʰɌDŽŮŤ [10 mg/ml Lysing enzymes (Sigma), 5 mg/ml Kitalase (~<ǂDzÄľ) in OM buffer] ʯœK˅Jįˁʥʘɛʐ ʤǬ&˅ðŲʝʊ30ʇʫāʬʑ’ɷ (ˣˊ˨˦˔, INCUBATOR Personal-10, 80 strokes/min, 4-6 h) ʝʤʋ˸̌˪˸̈˞˪˅ɌDŽŤʛʬ˞˵˦˧Ƹʯƫʝʤʰʦʊ1 mlʰ ST buffer˅ʢʰʯƯʽʔʯɏ¿ʝʊɅãKɡ ̒2,000 rpm, 5 min̓ ʝʤʋOM bufferʬST bufferʰ ɖ¿ (ǬƿŻ˅xʺ˸̌˪˸̈˞˪) ˅Pʰęʝʐ˞˵˦˧Ƹ ʯƫʝʤʋʚʰ˞˵˦˧Ƹʰ8WƬʸʫSTC buffer˅Zʒ˵˻˦˨ˉ̎˕ʝʊɅãKɡ (700 rpm, 5 min) ʫĩŮȌʰǬƿŻ˅ŗŎʜʡʤʋŧ˅ęʝʐ˞˵˦˧Ƹʯ˵˻˦

˪ʫƫʝʊɅãKɡ (2,000 rpm, 5 min) Üʊŧ˅ɛiʝʤʋŗŎʝʤ˸̌˪˸̈˞˪

ʯ5 mlƬÐʰSTC buffer˅Zʒʊ2ÐŜş (Ʌã2,000 rpm, 5 min) ʝʤʋÞʿ˂ʤ

˸̌˪˸̈˞˪ʰŗŎ˅1 mlʰSTC bufferʯEðŲʝʊ˪̐˿őǸƄȎ˅ƉʐʪųÐ

(20)

19 ǽ6ɿ īƠưʫƉʐʤPCRʰĮ

kæ ŪÐ (ʇ) ğɖ

Fusion PCR ›èkæ 94 2K

›èkæ 94 15Ʃ 30˚ˊ˔̊

ˈ˭̐̉̎˕ 60 30Ʃ

"ɔkæ 72 5K

"ɔkæ 72 10K

Long PCR ›èkæ 94 2K

›èkæ 98 10Ʃ 30˚ˊ˔̊

ˈ˭̐̉̎˕ʓʾʳ

"ɔkæ

68 1K/kb

ɿ "ɔkæ 72 10K ɿ

(21)

20

˅ū«ʝʤʋ

11. ˾˾̉ˍ˥̋̎˕̉˘̐̊ (PEG) ŘʯʾˁÙȩȯĉ

ÙȩȯĉʱʊVollmerʬYanofsky (Vollmer et al. 1986) ʰĚŘ˅đ›ʝʤItohʿ (Itoh et al. 1994)ʊTsugeʿ (Tsuge et al. 1990) ʓʾʳȪĨ (ȪĨ 2010)ʰĚŘʯÝ ʐǹʧʤʋ

ɿ ȶʝʤ˸̌˪˸̈˞˪ʰcɡʯʾˀȞȂʝʤ˸̈˪˸̈˞˪ðŲŤ80 μl (1.25ʀ108 1/ml) ʯʊ20 μlʰ40% PEG˅xʺSTC bufferʬʊ1-10 μlʰƆž˸̈˞̀˫DNA (100 ng/μl) ʏˁʐʱ/ʜʿʯǒžDNA (10-50 ng/μl) ˅ZʒʊŔʫ30KɖɧǕʝ ʤʋ900 μlʰ40% PEG˅xʺSTC buffer˅Zʒ­Ūʫ10KɖɧǕʝʤʋɧǕÜʊ

?kæŤ˅50ʇʯ.ʧʤ5 mlʰ0.8̑EƇ’ŽʯZʒ`KʯĐüʝʤʋ10 mlʰ 1.5%EƇ’ŽʯǾʡʊŠ_ʜʡʤʋǁ12ğɖÜʊ50ʇʯ.ʧʤ5 mlʰ1.0%²

Ÿ’ŽʯĥLJƕʯ?&ʕ100 ppmʯʮˁʾʑʊɆøƉʰ÷Ƈżȩ˅ZʒʤʋʢʰÜʊ ʢ˂ʣ˂ʰ˸̋̐˪ʯǾʡʊŠ_ʜʡʊ26ʇʫ’ɷʝʤʋ1 ȽɖÜʊJƃʝʤ˘̌˭

̐˅100 ppmʰ÷ƇżȩxĦɆø’Ž (PDA̔÷Ƈżȩ) ʯļʒǍʐʥʋ

12. ˸̌̐˷ʰ)Ȃ

ɿ DIG DNA Labeling Kit (̌˜̗̅ˤˊˈ˕˯˞˨ˉ˦˔˞) ˅ƉʐʪʊDIGŃȢdUTP

˅ƉʐʤPCR˅ǹʑʚʬʫʊ˸̌̐˷˅)ȂʝʤʋóɭʱŦʰ˿˭̅ˈ̊ʯÝʐǹ ʧʤʋDIGʫ̈˺̊ʝʤPCRkæŤ˅ʊ0.5ʀTBEʫȞȂʝʤ2.0̑ˈˑ̌̐˞˗̊

ʫ̈˺̊ʜ˂ʪʐʮʐPCRkæŤʬʬʼʯɣŒś]ʝʊDIGʯʾˀ̈˺̊ʜ˂ʪʐ ˁʚʬ˅ƢȘʝʤʋʚʰDNA˅˗̊úJʝʊ˸̌̐˷ʬʝʪƉʐʤʋ

13. ˚˛̎˷̌˦˨ˉ̎˕

ɿ ˚˛̎˷̌˦˨ˉ̎˕ʱȪĨ (ȪĨ 2010) ʰĚŘʯÝʐǹʧʤʋ˗˯̀˦˔DNAʰ ˬˊ̌̎ǡ (Hybond N+, GE˹̊˞˖ˈ) ʴʰȯFʱʊˈ̊ː̉Řʯʾˀǹʧʤʋʸʠʊ

˗̊˅UV chamberʫ˭˦˒̎˕ʝʊTransfer bufferʫ30Kʊ2ÐÌǼ_ʟˁʚʬʯʾ ʧʪ˗̊ ʰDNA˅īɒʯʝʤʋǎʐʪubuffer˅Ɖʐʊcapillary transfer (ķļ ʿ 1993) ʯʾʧʪ˗̊ ʰDNA˅ˬˊ̌̎ǡʯ24ğɖȯFʝʤʋȯFÜʊˬˊ

̌̎ǡ˅Neutralizing buffer ʫ30Kʊ2ÐƯʽʔʯāʬʑ (35 strokes/min) ʝʪ

~ʝʤʋŇʯʊ­Ūʫ30KźÜʊUV chamberʫDNA˅ˬˊ̌̎ǡʯŠ«ʝʤʋ DNA˅ȯFʝʤˬˊ̌̎ǡ˅˰ˊ˷̉ˤˊˡ̐˜̇̎Ťʫ65ʇʊǁ2-5ğɖ˸̋˰ˊ

˷̉ˤˊˡ̐˜̇̎ʝʤÜʊ˸̌̐˷˅xʺ 15 ml ʰ˰ˊ˷̉ˤˊˡ̐˜̇̎Ťʬ>˂

Ĥʒʊ65ʇʫǁ15ğɖ˰ˊ˷̉ˤˊˡ̐˜̇̎˅ǹʧʤʋʢʰÜʊˬˊ̌̎ǡ˅65ʇ

(22)

21

ʊ0.1% SDS˅xʺ0.1ʀSSC bufferʫ30Kʊ2ÐŜşʝʤʋˬˊ̌̎ǡ˅buffer 1 ʫ5KɖÌǼ_ʝʊʢʰÜbuffer 2 ʫʊ45Kāʬʑʝʤʋ

ɿ ÷& [Anti-digoxigenin-AP fragment (Roche)] ˅buffer 1ʫ12ʯÇɎʝʊ20 ml ʯˬˊ̌̎ǡ˅>˂ 25 KɖāʬʑÜʊ0.3% Tween20 (Polyoxyethylene Sorbitan Monolaurate) ˅xʺbuffer 1ʫ20Kʊ2ÐŜşʝʤʋʢʰÜʊˬˊ̌̎ǡ˅buffer 3 ʫ5KɖÌǼ_ʝʤÜʊ10 μlʰCSPD (Roche) ˅xʺ1 mlʰbuffer 3˅˸̈˞˥˦

˔˱˦˔ʯƫʝʤˬˊ̌̎ǡʯZʒʊ37ʇʊĢɾ_ʫ 10KɖɧǕʝʤʋĥÜʯʊˬˊ

̌̎ǡ˅Xǒ˶ˉ̊́ (FUJI MEDICAL X-RAY FILM, Fuji Film) ʬʬʼʯɧǕʊʏ ˁʐʱ̊̀˯ˊ̂̐˝ˈˬ̈ˊ˛̐ (±š˶ˉ̊́ʊLAS4000EPUVmini-TU) ʫ˜˕

ˬ̊˅ĽJʝʤʋĽJÜʊˬˊ̌̎ǡ˅buffer 4ʫ20Kʊ2ÐŜşʝʤʋEÐ˰ˊ˷

̉ˤˊˡ̐˜̇̎˅ǹʑ•t˅ǙʒʊProbe stripping buffer ʊ37ʇʫ30Kɖāʬʑʟ ˁʚʬʫ˸̌̐˷˅ɛiʝʤʋǎʐʪˬˊ̌̎ǡ˅2ʀSSC ʫ 20Kʊ2 ÐŜşʝʊ­

Ūʫźʜʡ.§ʝʤʋ

14. ƑƑhèĽ«

ɿ ƑhèĽ«ʯƉʐˁǜ¥ðŲŤʰȞĔʓʾʳǮʴʰąƭʱȪĨ (ȪĨ 2010) ʰĚŘʯÝʐǹʧʤʋ

14-1. ǜ¥ðŲŤʰȞȂ

PDAʯǬ˅ļǬʝʊ2-3ĜÜV8²Ÿ’ŽʯļǬʝʤʋˈ˦ˠˊʯ*Ɖʟˁʤʻ ʯ1ǬĸØʤˀ5-10 IJļǬʝʤʋ˜̄̐̋ʯ8WƬÐʊǬƿʕȆʧʤğʯʊBLB̈ ˊ˪˅ĠʊŸ¶ʝʤʋʢʰÜʊēĜɖɧǕʝʊ’Žǽɩʯǜ¥ʕȇʒ£ʻʤɬʯ ǜ¥˅…lʝʤʋ’Žʯ0.1% tween20˅xʺůǬœ˅5 mlƬÐʔʘʊ˙́˺̈ʫ ǽɩ˅ďˀʊǜ¥˅ȿɡʜʡʪ˴̐ː̐ʯɠʻʤʋ˴̐ː̐DʫʾʗčüʝʤÜʊ˒

́̍ˊ˸ʫŴɁʟˁʚʬʫ(KʮǬƿ˅ɛiʝʤʋē…ɅãʯʾˀŜşʝʤÜʊǜ¥

˅˪̐˿őǸƄȎʫȎūʝʊ0.1% tween20˅xʺůǬœʫ1061/mlʯȞĔʝʤʋ

14-2. ąƭ¬ɹ

ǜ¥ąƭʱÙȩȯĉ&ʮʭ˅õʑʤʻʊ50 ml˥̅̐˷˅*ʐʊǹʧʤʋ˚̎˸̊

ļżʱLmˀǮ˅*ƉʝʊǨʗœʫŜşʝʤÜʊ˒́ˣˏ̊ʫœK˅þʖmʧʤʋʚ ʰLmˀǮ˅ʊȑ1ʫÞʿ˂ʤǜ¥ðŲŤ˅5-10 ml>˂ʤ50 ml˥̅̐˷ʰ ʯŢʝʤʋǜ¥ðŲŤʕǮʰǽɩʯǹʖũˁʾʑʯǓʽʔʯ˥̅̐˷˅…ȯʜʡʤʋ ʢʰÜʊǮȀ˅ǽʯʝʪ­ŪʓʾʳŬÐ 100%ʰ˥̄̎˱̐Dʫ 3-5 ĜɧǕÜʊǮ ʰžî˅˩˝ˣ̊ː̂̈ʫČÚʝʤʋ

(23)

22 15. AALŏŏDŽĽ«

ɿ AALŏDŽʰúJʊŏDŽʰˈ˦ˠˊʓʾʳHPLCȌİʱȪĨ (ȪĨ 2010) ʰĚŘ ʯÝʐǹʧʤʋ

15-1. AALŏDŽʰúJ

ɿ PDA’ŽʫƇǛʜʡʤǬ&˅̂˞ʫ5 mmȋʯdžĘʝʊ20ʰĘŻ˅50 mlʰ›Ř

̉˥̄̐˟’Žʯąƭʝʊ1-2ȽɖɧǕ’ɷʝʤʋ’ɷ˃Ť˅10-20 ml˘̐˭̎˕˥

̅̐˷ʯƫʝʊʉ80ʇʫHNJʜʡʤʋHNJʝʤ˥̅̐˷˅1-2ĜʶʭHNJźŅʯʔ ʘʤʋHNJźÜʊ˥̅̐˷ʯ1 mlʰ50%ˈˠ˪˭˪̉̊˅Zʒʪʊ1ğɖāʬʑʝʤ (ˣˊ˨˦˔, INCUBATOR Personal-10, 80 strokes/min)ʋāʬʑÜʊ13,000 rpmʊ1K Ʌãʝʊŧ˅ Sep-Pac C18 ː̈́ (Waters) ʯȹʝʪǂ_ʝʤʋː̈́ʱĥNʯʊ 100%ˈˠ˪˭˪̉̊˅ȹʝʊʢʰÜ milliQ ˅ȹʝʪː̈́D˅ŜşʝʤʋŇʯ˚̎˸

̊ (ŧ)ʊmilliQ (2 ml)ʊ15%ˈˠ˪˭˪̉̊ (2 ml) ˅ɭʯ>˂ʤʋĥÜʯ70%ˈˠ

˪˭˪̉̊ (2 ml) ʫúJʝʤʋúJʝʤ AALŏDŽʱ-4ʇʫ.§ʝʤʋʚ˂˅Ǯʴʰ ˈ˦ˠˊʓʾʳHPLCʯ*Ɖʝʤʋ

15-2. Ǯʴʰˈ˦ˠˊ

ɿ ˜̄̐̋Dʯ5 mmȋƬÐʰ˃ǃ (Whatman, 3MM CHR) ˅Ǖʖʊȑ15-1ʫÞ ʤúJż˅25 μlŰʝʊʝʹȴʸʡʤʋ˔̉̐̎˺̎˥Dʫɴʜʡʊˈˠ˪˭˪̉̊

˅ǰƒʜʡʤʋĽ«ƉʰǮʱLmˀǮ˅*ƉʝʊǮʰȀʯ˒́̍ˊ˸˅Ȱʗďˀʨʘ ˁʚʬʫ7˅ʘʤʋ7ɊKʯúJż˅ʝʹȴʸʡʪʓʐʤ˃ǃ˅ʰʡʊ25 µl ʰœ

˅Űʝʊ­ŪʊŬÐ100%ʰ˥̄̎˱̐DʫɧǕʝʤʋ3-5 ĜÜʰǮʰžî˅˩˝

ˣ̊ː̂̈ʫČÚʝʤʋ

15-3. HPLC

ɿ o-phthalaldehyde (OPA) ʯʾˀǶ<Ț·&_ʝʤ’ɷ˃Ť ʰAALŏDŽʰHPLC ʯʾˁĽJʱʊ=ƂʿʰĚŘ (Kodama et al. 1995) ˅Ɋđ›ʝǹʧʤʋOPAȔDz ʱʊ1 mlʰ100%̂ˣ˯̐̊ʯŮʔʝʤ40 mgʰOPAʬ50 μlʰ2-mercaptoethanol ʬ5 mlʰ0.1 M˼ˋɍˬ˪̉ˋ́ǓǻŤ (pH 9.5) ˅ťtʝʪ)ñʝʤʋȔėŮŤ25 μlʯOPAȔDz125 μl˅ťtʝʤÜʊ30Ʃɖ˽̊˨˦˔˞ʝʊ2K30Ʃɖʊ­Ūʫ ɧǕʝʤÜʊƙʦʯHPLCː̈́ʯŚ>ʝʤʋHPLCKİʱʊ655 LC˘̎˪̌̐̈̐ʊ F-1050 Ƕ<ĽJ„ʊD-2500 ˔̌˿˪ˊ̎˨˕̋̐ˣ̐ (ĜƲ) ʯʾʧʪǹʧʤʋː̈

́ʱʊDevelosil ODS-UG-5 (4.6ʀ250 mmʊɐĭ_¨) ʓʾʳDevelosi l ODS-UG-5 ˑ̐˫ː̐˪̉˦˝ː̈́ (4.0ʀ10mmʊɐĭ_¨) ˅Ɖʐʊ̂ˣ˯̐̊/0.1 M ̉̎ɍ œDŽˬ˪̉ˋ́ǓǻŤ (pH 3.35)ʊ75 : 25 (v/v) ʰ٤ǀʫʊ0.7 ml/minʰŞȺʫ

(24)

23

ŮJʝʤʋʮʓʊĽJʱ[ȫřɔ335 nmʓʾʳĽJřɔ440 nmʫǹʧʤʋ

16. KOĸĸʴʰƚȁ¬ɹʊɆøʓʾʳŅǝȌİ

ɿ KO ĸʴʰɇ ¥ʰƚȁʱʊʰóɭʫǹʧʤʋʸʠʊƚȁʟˁɇ ¥ʰɕ£

˘˫̎ʰ1 kb ƬÐŞʊLJň˘˫̎ʰ 0.5 kbƬÐŞʯ˸̈ˊ˿̐˅ȒȎʝʊlong PCRʯʾˀʊǒžʰ PCRƈż˅—ÊʝʤʋʚʰPCRƈżʬ˝ˌˮ˨ˉ˜̎ǚèɇ

¥ (nptII) ˅xʺ˸̈˞̀˫ʊpII99˅˘˪̈̎˞˶ˎ̐̂̐˜̇̎ʟˁʚʬʫÙȩȯĉʝ ʤʋÙȩȯĉʱǒžʰPCRƈż˅50 ngƬÐZʒˁʚʬʬʊ˸̈˞̀˫DNA˅100 ng uğʯZʒˁœʱĬėʓʾʳĚŘʰ 11ʊPEG ŘʯʾˁÙȩȯĉʯÝʐǹʧʤʋ ʸʤʊƚȁĸʰɆøʊƑhèʊŏDŽĽ«ʓʾʳƒƃȌİʱȑĚŘʯʾˀǹʧʤʋ

17: ˲̊˞˶ˉ̐̊˫˗̊ɣŒś] (PFGE) 17-1Ķǩ& DNAʰȞȂ

ɿ Ķǩ&DNAʰȞȂʱʊBrodyʬCarbonʰĚŘ (Brody et al. 1989) ˅đ›ʝʤȪ Ĩ (ȪĨ 2010)ʰĚŘʫǹʧʤʋȑ 2-10ʫcɡʝʤ˸̌˪˸̈˞˪ðŲŤ˅GMP bufferʫEðŲʝʊ2.0×10̖1/mlʯʮˁʾʑʯȞĔʝʤʋʚʰðŲŤʯ55ʇʫ.Ūʝ ʪʓʐʤ1.4%%Ƿŵˈˑ̌̐˞ (Agarose low melt preparative grade (BIO-RAD) in GMP buffer) ˅ƶɑZʒʊʾʗĐüʝʤʋʚ˂˅˸̈˕)ȂƉmold (BIO-RAD) ʯ KŚʝʊ5 Kɖ4ʇʫɧǕʝʊŠ_ʝʤʰ˅ƢȘʝʪ˸̈˕˅ʔʿmˀJʝʤʋ)Ȃ ʝʤ˸̈˕ʱSE buffer ʫ55ʇʊ24ğɖIƅʝʤʋˣ̎˲˔ȩɛiʰʤʻʊ1%

N-Lauroyl sarcosine sodium-salt (SLS) ʓʾʳ2 mg Proteinase K (Merck) ˅xʺ1 mlʰ10×ET buffer ʯ˸̈˕˅ƫʝʊ50ʇʫ20ğɖIƅʝʤʋ˸̈˕ʱ1×ET bufferʫ2ÐŜşʝʤÜʊubuffer ʯ4ʇʫ.§ʝʤʋ

17-2˲̊˞˶ˉ̐̊˫˗̊ɣŒś]Ř (PFGE)

ɿ Ķǩ&ʰɣŒś]ʱȪĨ (ȪĨ 2010) ʰĚŘʯÝʐǹʧʤʋ˗̊ʱ Pulsed Field Certified Agaroseʸʤʱ%Ƿŵˈˑ̌̐˞ (BIO-RAD) ˅ʊbufferʱ0.5×TBE buffer ˅Ɖʐʤʋʸʤś]ǿǕʱ Contour-clamped Homogenous Electric Field Dynamically Regulated IIʏˁʐʱIII (CHEF-DRIII) system (BIO-RAD) ˅*Ɖʝʤʋ …ǹʧʤś]Įʱǽ7ʯƣʝʤʋś]LJÜʊˈˑ̌̐˞˗̊˅0.5 μg/mlǣ_

ˍ˥˝ˋ́ (EtBr) ʫĶǩʊǰƎœʫǞǩÜʊUV˪̈̎˞ˊ̊̀ˮ̐ˣ̐ʫȊ³ʝ ʤ ʋ ʸ ʤ ˚ ˊ ˟ ˿ ̐ ː ̐ ʬ ʝ ʪ ʊSaccharomyces cerevisiaeʊShizosaccharomyces pombeʓʾʳHansenula wingei (BIO-RAD) ˅Ɖʐʤʋ

(25)

24 ǽ 7 CHEFʰĮ

LĤğɖ ɣŒ ğɖ ˚ˊ˟ ŪÐ ˗̊ųÐ

A 1 0.5 s 6 V/cm 0.5 h 50-150 kb 10 1.0%

2 8 s 0.5 h

3 1 s 3 h

4 2 s 3 h

5 4 s 6 h

6 8 s 6 h

B 1 5-25 s 5 V/cm 22 h 100-400 kb 8 1.0%

2 1-40 s 18 h

C 1 3600-1800 s 1.5 V/cm 115 h 0.5-5.0 Mb 8 0.8%

2 1800-1300 s 1.5 V/cm 24 h 3 1300-800 s 1.8 V/cm 28 h 4 800-600 s 2.4 V/cm 28 h

D 1 120 s 5.5 V/cm 12 h 0.5-2.0 Mb 8 0.8%

2 180 s 12 h

E 1 60 s 6 V/cm 15 h 1.0-2.8 Mb 14 0.8%

2 90 s 6-8 h

F 1 1500-3000 s 1.5 V/cm 48 h 1-5 Mb> 10 0.8%

2 900-1500 s 1.8 V/cm 40 h 3 480-900 s 2.4 V/cm 57 h

G 1 1-6 s 6 V/cm 11 h 5-75 kb 14 1.0%

H 1 120-180 s 6 V/cm 24 h 0.5-1.2 Mb 14

I 1 120 s 4 V/cm 13 h 0.5-3 Mb 14 0.8%

2 240 s 13 h

3 360 s 13 h

J 1 50-90 s 6 V/cm 12 h 0.5-1.0 Mb 14 0.8%

?ʪ0.5xTBE ˱˦˶ˇ̐˅Ɖʐʪǹʧʤʋ

(26)

25 18: ɇɇ ¥˼̃̌˕ʰ˞˔̉̐˭̎˕

ɿ ǫĵƑǬ As-27 ʓʾʳ AL12 ʰ˫̈˶˪˗˯́˜̐˔ˍ̎˞Ȍİ˅ǹʐʊʢ˂ʣ˂

5847 ʓ ʾ ʳ 2016 ʰ ˘ ̎ ˨ ˉ ˕ ʕ Þ ʿ ˂ ʤ ʋ ʚ ʰ ˩ ̐ ˣ ˅ “ ʯ BioEdit (http://www.mbio.ncsu.edu/bioedit/bioedit.html) ˅*ʐʊĽDžʝʤʐɇ ¥ɋM˅˔

ˍ̉̐ʯʝʊLocal BLASTĽDž˅ǹʧʤʋ˔ˍ̉̐ʯʱA. nidulansʰɇ ¥˅Ɖʐʤʋ ˈ̀˯ɍʰūʯʱSoftberry FGENESH (http://linux1.softberry.com/berry.phtml) ˅Ɖʐʤʋ

(27)

26 Ƶ

Ƶ3Ƴɿ ǫĵƑǬʯʓʘˁƑhèɗȼɇ ¥ʰĄDž Ƶ1ƹɿ Ïȟ

ɿ ˪˿˪Ƒhʫʏˁ˪˿˪ˈ̊ˣ̐ˬ̉ˈǫĵƑǬ (A. alternata tomato pathotypeʊ ʊǫĵƑǬ) ʱ°ŽƏƕAALŏDŽ˅Ƈƈʝʊínè˪˿˪ƭʯʰʹǯʝʐ

™Ŋ˅ÔʖȫʚʟʋAAL ŏDŽʱʊɅǔʰ Fusarium ƭʕƇƈʟˁ˿ˊ˘˪˒˜̎ʊ˶

̃˭˜̎ʰŀȻɳǔ&ʫʏˀʊʢ˂ʣ˂ʰŏDŽƇtñʯäɮʫʏˁ˾̉˖˥˫tñ ɌDŽ (PKS) ɇ ¥ (ǫĵƑǬʯʓʐʪʱ ALT1ʊFusarium ƭʯʓʐʪʱ FUM1) ʕ ʊ ˩ ˉ ˝ ˌ ˮ ̋ ̐ ˪ ˸ ̈ ˊ ˿ ̐ ˅ * ʧ ʤ ˔ ̌ ̐ ˭ ̎ ˕ ʯ ʾ ˀ c ɡ ʜ ˂ ʪ ʐ ˁ (Akamatsu et al. 2003, Proctor et al. 1999) (‰1)ʋʚ˂ʿɇ ¥ʱˈ̀˯ɍ̋˺̊ʫɺ ʐƚuèʕʏˀʊʸʤ{ȳʰ˜̐˔ˍ̎˞Ȍİʯʾˀʊʐʯƚuèʰɺʐɇ ¥˔

̈˞ˣ̐ʕȇJʜ˂ʤʋǫĵƑǬʫʱʊCDC ʰ?ɋMȌİʯʾˀʊ13 ɇ ¥ʔʿʮ ˁAALŏDŽƇtñɇ ¥˔̈˞ˣ̐ (ALT˔̈˞ˣ̐) ʕʊCDCʯ2ˠ˦˪Ñʝ ʪʐˁʚʬʕƣʜ˂ʪʐˁʋʸʤʊØƠư­ʫʱʊCDC ʰ?ɋMʰȌİʬʱPʯʊ Ň˜̐˔ˍ̎˚̐ʊ̌˜̅454 FLX ʓʾʳˊ̊̀ˬHiSeq˅*ƉʝʤǫĵƑǬ

˫̈˶˪˗˯́Ȍİ˅ǹʐʊʶʷ?˗˯́ʰ˜̐˔ˍ̎˞é”˅Þʪʐˁʋ

ɿ īƠưʫʱʊǫĵƑǬʰ˗˯́é”˅QƉʝʤƑhèɗȼèɇ ¥ʰĄDžʓʾ ʳŅǝȌİ˅ȔʹʤʋǫĵƑǬʱʊȶʰʾʑʯ?˗˯́ʰ˫̈˶˪˗˯́é”ʬʬʼ ʯʊAALŏDŽƇtñʯɗ˄ˁALT˔̈˞ˣ̐ʕÑʟˁCDCʰª?ʮɋMé”ʕ QƉJįˁʋʸʤʊʚ˂ʸʫʯDZƮʜ˂ʤȼʰɇ ¥KO¬ɹʰ˸̌˪˘̊ʯʾˀʊ

¯ĞʯƘƕɇ ¥ʰŅǝȌİʕqǝʫʏˁʋ

ɿ 13ɇ ¥ʬĆ«ʜ˂ˁALTɇ ¥ʱʊʚ˂ʸʫʯALT1-4ʊ7-9ʓʾʳ13ʰ8ɇ

¥ʯʓʐʪŅǝȌİʕǹ˄˂ʪʓˀʊʚ˂ʿʰʑʦALT1-4ʓʾʳALT13ʱAALŏ DŽƇtñʯɗʝʪʐˁʚʬʕƣʜ˂ʪʐˁ (ȪĨ 2010, ı 2010, ɂ 2010, Š 2011)(ǽ1)ʋĚʊABC transporterʊshort chain dehydrogenase/reductaseʊ fatty acyl-CoAʊphytanoyl-CoA synthetaseʓʾʳpeptide synthetase˅ʢ˂ʣ˂˘̐

˫ʟˁʬĆ«ʜ˂ˁALT5ʊ6ʓʾʳ10-12ʰ5ɇ ¥ʱŅǝĩƝʫʏˁʋʚ˂ʿALT ɇ ¥ʰŅǝȌİ˅ǹʑʚʬʯʾˀ AAL ŏDŽƇtñljȮʕȖdžʯȜĝJįˁʬǙ ʒʿ˂ˁʋ

ɿ ǫĵƑǬʯəʿʠʊƑhèA. alternataʰʗʱʊʢ˂ʣ˂ʰHSTƇtñɇ ¥ ʓʾʳɇ ¥˔̈˞ˣ̐˅CDCʯ.ÿʝʪʐˁʚʬʕĝʿʔʬʮʧʪʐˁʕʊCDC ʰɇ ¥ʰʹʕƑhè˅ûʧʪʐˁʰʔʊCDCœʰessential chromosome (EC) ʯʼƑhèɇ ¥˅.ÿʝʪʐˁʰʔʱKʔʧʪʐʮʐʋʰļżƑhǬʯʓ

(28)

27

ʐʪʢʰƑhèʯɏȅʫʏˁʚʬʕƣʜ˂ʪʐˁ̂̈˭̎Ƈtñʯɗ˄ˁɇ ¥

‰1ɿ ˶̃˭˜̎ʬAALŏDŽʰŀȻ

(29)

28

(Kubo et al. 1982) ʽGˣ̎˲˔ȩα˚˷̆˭˦˪ (Wang et al. 2010) ʰŅǝȌİʕ

A. alternataʯʓʐʪǹ˄˂ʤʕʊʭ˂ʼƑhèʯäɮʫʱʮʐʚʬʕƣʜ˂ʪʐ

ˁ (Takano et al. 1995, Kheder et al. 2012, Yamagishi et al. 2006, Tsuge et al. 1990)ʋ ɿ ˗˯́é”ʕŝƉʫʖʮʔʧʤɬʱʊʏˁǬʫƑhèɇ ¥ʕȇJʜ˂ʤʬʝʪʼʊ ʢʰɋMʕƭ˅ȬʒʪɺÐʯ.§ʜ˂ʪʐˁʾʑʮ•tœʱʊ˔̌̐˭̎˕ʱ‡

ɢʫʏʧʤʋØƠư­ʫʼʊGˣ̎˲˔ȩAېn¯&(GPCR) ʰ˔̌̐˭̎˕˅Ȕ ʹʤʕʊ˔̌̐˭̎˕ʱJįʮʔʧʤʋĚʊ6¬ɹʯʾˀʊǫĵƑǬʰ?˗˯́

˫̈˶˪˩̐ˣʔʿʊGPCR ʰ˼̃̌˕˅ĽDžʝʤʬʚ˃ʊēɇ ¥ʕ3ȁɇ ¥ʬʝ ʪɆøʜ˂ʤʋʚʰʾʑʯʊTʱ˔̌̐˭̎˕ʕɨÉʯɢʝʔʧʤɇ ¥ʕ˗˯́

é”˅“ʯĽDžqǝʫʏˁʚʬʔʿʊěƝʰƑhèɗȼɇ ¥ʯ“ʩʖʊǫĵƑǬ ʯʓʘˁƑhèɗȼɇ ¥ʰĄDž˅Ȕʹʤʋ

(30)

29 Ƶ

Ƶ2ƹɿ ĬėʬĚŘ

1: +ȔǬ

ɿ +ȔǬʯʱǫĵƑǬAs-27Ǭĸʊ̉̎˙ĖŵǭǮƑǬIFO8984Ǭĸʓʾʳˊ˥˙

ɾĖƑhNAF8Ǭĸ˅˅*ƉʝʤʋǬĸʰ’ɷʓʾʳ.§ʱ2-1ʯÝʧʤʋ

2: DNAĎ)

ɿ DNAʽRNAʰúJʊƼcʮĎ)ʱƵ2ƳʯÝʐǹʧʤʋ

3: KOƉ˘̎˞˪̈˔˪ʰ)ñʓʾʳ KOĸʰ)J

ɿ ˘̎˞˪̈˔˪ʰ)ȂʓʾʳKOĸʰ)Jʱ2-9, 10, 11ʯÝʐǹʧʤʋKOĸʰƢ ȘʱPCRʯʾˀʊhphʰDɊɯ‘ʊsɇ ¥ʰDɊɯ‘ʓʾʳëʰ$ǕʫLjĉ ʒʕȫʖʤʚʬ˅ƢȘʟˁHomoʰɯ‘˅—Êʝʤʋ

4: ˚˛̎˷̌˦˨ˉ̎˕

ɿ 2-14ʯÝʐʊsɇ ¥ʰKO3ȁĸʰ˚˛̎˷̌˦˨ˉ̎˕˅ǹʧʤʋ

5: ƒƃȌİ

ɿ ʚ˂ʿsɇ ¥KOĸʰ¬ɞʰƒƃ˅Ȟʵʤʋ2-4ʯÝʐRNA˅úJÜʊ2-5ʯ ÝʐʊcDNA ʰtñ˅ǹʧʤʋʚʰ cDNA ˅˨̎˸̋̐˪ʯɇ ¥ʰDɊɯ‘˅—

Êʟˁ˸̈ˊ˿̐ʫPCR˅ǹʐʊʢʰ˱̎˫ʰĦŶʫƒƃ˅Ȟʵʤʋ

6: ƑhèʓʾʳŏDŽƇƈǝĽ«

ɿ ƑhèĽ«ʓʾʳŏDŽƇƈǝĽ«ʱ2-14, 15ʯÝʐǹʧʤʋʸʤʊHPLCȌİʼ uŁʯ2-15-3ʯÝʐǹʧʤʋƑĖɩƮʰū«ʱ˶̉̐ˢ˶˪ʰImage J˅Ɖʐʤʋ

7: KOĸʰƚȁ¬ɹ

ɿ ƚȁ¬ɹʱʊɐèĸʬŐȱʝĝʿʔʮ›_ʕʏˁ KO ĸʯʰʹǹʧʤʋƚȁǬĸ ʰ)JʊɆøʓʾʳŅǝȌİʱ2-16ʯÝʐǹʧʤʋ

8: Ǭƿñɔʓʾʳǜ¥˚ˊ˟ʰŐȱ

ɿ ˘̌˭̐ŐȱʯʱPDA, V8, crossing’Žʓʾʳcrossing’Žʯʢ˂ʣ˂+5%ʰ sucrose, glucoseʓʾʳmannitol˅ŦZʝʤ’Žʰ˸̋̐˪˅*ƉʝʤʋŤ&’Žʫ ʰǬƿñɔŐȱʯʱPDBʓʾʳ›Ř̉˥̄̐˟’Ž˅Ɖʐʤʋǁ2ȽɖʊɧǕʸʤ

(31)

30 ʱɤʬʑ’ɷʝʊɐèĸʬ›Əĸ˅Őȱʝʤʋ

ɿ ǜ¥˚ˊ˟ʱƑhèĽ«ʯƉʐʤǜ¥˅Ȋ³ʯƉʐʤʋɲáɓʓʾʳː̂̈ʱ Nikon, Eclipse TE300 Microscope˅Ɖʐʤʋ

9: Real-time PCR

ɿ AaLaeAɇ ¥ʰKOĸʯʓʘˁCDĶǩ&ʯÑʟˁɇ ¥ʰƒƃȌİʱ2-5 ʯÝʐǹʧʤʋŽʯRNAʰųÐ˅ɐèĸʬKOĸʫćʒˁʚʬʯƎëʝʤʋ

10: ɇɇ ¥ʰÑĶǩ&ʰŽ«

ɿ ˸̌˪˸̈˞˪ʱÙȩȯĉʬuŁʯ2-10ʯÝʐKɡʝʤʋ2-17ʯÝʐʊɣŒś]˅

ǹʧʤÜʊ2-13ʯÝʐʊ˷̌˦˨ˉ̎˕˅ǹʧʤʋ

(32)

31 Ƶ

Ƶ3ƹɿ NJij

ɿ 1. CD&7@)6;$

1-1. ALT@<=" KO'?!

ɿ ALT ˔̈˞ˣ̐ʯ§ʟˁ13ʰ ALTɇ ¥ʰʑʦʊʚ˂ʸʫʯŅǝʕ”zʜ˂ʪ

ʐʮʐ ALT5ʊ6ʊ10ʊ11 ʓʾʳ 12 ʰŅǝȌİ˅ǹʧʤʋʚ˂ʿɇ ¥ʱʢ˂ʣ˂

ABC transporterʊshort chain dehydrogenase/reductaseʊfatty acyl-CoA synthetaseʊ phytanoyl-CoA synthetaseʓʾʳpeptide synthetase˅˘̐˫ʝʪʐˁʬêʜ˂ʪʐ ˁ (ǽ1)ʋʸʤʊ˶̃˭˜̎Ƈtñʯɗ˄ˁFUMɇ ¥ʊFUM19ʊ13ʊ10ʊ3ʓʾʳ 14 ʬʢ˂ʣ˂ɺʐƚuèʕȘʻʿ˂ʪʐˁʋʜʿʯʊʚ˂ʿɇ ¥ʰʑʦʊALT5ʊ6 ʓʾʳ10ʱīǬʰ˗˯́ ʯ2˘˵̐§ʝʊALT11ʓʾʳ12ʱ4˘˵̐§ʟ ˁʚʬʕCDCʰŀȻȌİʔʿȇJʜ˂ʪʐˁʋ

ɿ ʚ˂ʿɇ ¥ʰKO¬ɹʱʊĬėʬĚŘʫȶʵʤʾʑʯPEGŘ˅*ʧʤÙȩȯĉ ʯʾˀǹʧʤʋÙȩȯĉ&ʔʭʑʔʰƢȘʱʊ·>ʝʤ÷Ƈżȩǚèɇ ¥ʯ´æ ʟˁ÷Ƈżȩʕ100 ppmŦZʜ˂ʤPDA’Žʫ3ÐɆøʟˁʚʬʫǹʧʤʋɆøʝ ʤÙȩȯĉ&ʱʊĬėʬĚŘʫȶʵʤʾʑʯ PCR ʬ˚˛̎Ȍİ˅Ljʹt˄ʡʤĚ ŘʫKOĸʔʭʑʔʰƢȘ˅ʝʤʋ

ɿ ALT511ʓʾʳ12ʫʱʊ500ʰÙȩȯĉ&ʕÞʿ˂ʤʕʊPCRʯʾˁƚuLj ȴʹʰƢȘʫ3ȁĸʱÞʿ˂ʮʔʧʤʋALT6ʫʱ65ʰÙȩȯĉ&ʕÞʿ˂ʊʢʰ ʑʦʰ 12 Ǭĸ˅ PCRʫƢȘʝʤNJijʊ2 ǬĸʫŃƕɊKʰ˱̎˫ (insert) ʕÞʿ

˂ʠʊ˄ˀʯƚuLjȴʹʯʾʧʪƇʞˁ˱̎˫ (homo) ʕĽJʜ˂ʤ (‰ 2a)ʋʚ

˂ʿ 2 Ǭĸʰ˚˛̎ȌİʫʱʊƚuLjȴʹʯʾʧʪǕĉʜ˂ˁɋM˅˸̌̐˷ʬʝ ʤ•tʊ˱̎˫ʱʹʿ˂ʮʔʧʤ (‰2b, c)ʋʚ˂ʿʰNJijʔʿʊʚ˂ʿ2Ǭĸ˅KO ĸ (2 ˘˵̐ʬʼơ™ʜ˂ʤĸ)ʊ6H1 ʓʾʳ6H8ʬʝʊɘʰ¬ɹʯƉʐʤʋʸʤ 1

˘˵̐KO ĸ (1 ˘˵̐ʱơ™ʜ˂ʪʐˁʕŋˀʰ˘˵̐ʱŶ7ʮĸ) ʬƣʜ˂ʤ 6H10ĸ˅˘̎˪̌̐̊ĸʬʝʪɘʰ¬ɹʯƉʐʤʋALT10ʫʱʊ90ʰÙȩȯĉ&

ʕÞʿ˂ʊ8ǬĸʕKOĸʬƣʜ˂ʤʋʚ˂ʿ8Ǭĸʰʑʦ2Ǭĸ (10H36ʓʾʳ 10H39) ˅KOĸʬʝʊʸʤʊ1˘˵̐KOĸʬƣʜ˂ʤ10H44ʓʾʳ10H45˅˘̎

˪̌̐̊ĸʬʝʪɘʰ¬ɹʯƉʐʤʋ ɿ

1-2-1. ALT6KO'/ AAL*3-.6(

ɿ ALT6KO ĸʰƑhè˅Ľ«ʟˁʤʻʊĬėʬĚŘʫȶʵʤʾʑʯǜ¥˅ȞĔʝʊ

ínè˪˿˪ƭʊìƝ˶ˇ̐˞˪ʯąƭʝʤʋKOĸʊ6H1ʓʾʳ6H8ʬʼʯɐƇĸ ʫʹʿ˂ʤƑĖʱʹʿ˂ʮʔʧʤʋĚʊ1˘˵̐KOĸʫʏˁ6H10ʱɐƇĸʬu

(33)

32

a

b

c

‰2ɿ PCRʓʾʳ˚˛̎˷̌˦˨ˉ̎˕ʯʾˁALT6KOĸʰɆø a; PCRʯʾˁALT6KOĸʰɆø

homo; ƚuLjȴʹʯʾˀƇʞˁ˱̎˫

insert; ƚuLjȴʹʯʾˀhphːˠ˦˪ʬǕĉʜ˂ˁ˱̎˫

hph; ˰ˊ˕̌˿ˊ˜̎Bǚèɇ ¥ʰDɊɯ‘

exp; ’ɷ5ĜƘʰRNA˅úJʝcDNA˅tñÜʊALT6ʰƒƃ˅RT-PCRʫƢȘ ʝʤʋ

b; ALT6KOĸʰ˚˛̎˷̌˦˨ˉ̎˕

˸̌̐˷; ALT6 A

c; ALT6KOĸʰ˚˛̎˷̌˦˨ˉ̎˕

˸̌̐˷; ALT6 insert

As-27; ɐèĸʊ6H1, 6H8; ALT6KOĸʊ6H10; 1˘˵̐KOĸ

(34)

33

ƶʰƑĖʕʹʿ˂ʤ (‰3a)ʋĬėʬĚŘʰ15-1-1ʓʾʳ15-2ʯÝʐʊŏDŽúJʓ ʾʳŏDŽƇƈǝĽ«˅ǹʧʤʋʢʰNJijʊɐƇĸʓʾʳ1˘˵̐KOĸʊ6H10ʫʱ

™Ŋʕʹʿ˂ʤʋĚʊALT6KOĸʊ6H1ʓʾʳ6H8ʫʱʊ?ʗ™Ŋʱȇʿ˂ʮʔʧ ʤ (‰3b)ʋAALŏDŽʰ«ɑʰʤʻHPLCȌİ˅ǹʧʤʋɐƇĸʓʾʳ1˘˵̐KO ĸʫʱʊAAL-TA˅ƣʟ˵̐˔ʕĽJʜ˂ʤʋĚʊKOĸʊ6H1ʓʾʳ6H8ʫʱʊ AAL-TA˅ƣʟ˵̐˔ʱĽJʜ˂ʮʔʧʤ (‰3c)ʋŏDŽɑʰ«ɑʯʾˀʊɐƇĸʫ ʱ71.5 µg/mlʊKOĸʊ6H1ʓʾʳ6H8ʫʱʬʼʯ0 µg/mlʊ1˘˵̐KOĸʊ6H10 ʫʱ24 µg/mlʰŏDŽʕĽJʜ˂ʤ (ǽ8)ʋ

1-2-2. ALT6KO''1:D

ɿ ALT6KOĸʰƚȁʱʊĬėʬĚŘʯÝʐʊ˘˪̈̎˞˶ˎ̐̂̐˜̇̎ʯʾˀǹʧʤʋ

˝ˌˮ˨ˉ˜̎ǚèɇ ¥ʓʾʳ·>ʝʤɇ ¥ʰDɊɯ‘˅PCRʫĽJʟˁʚʬ ʫʊɇ ¥ʰ·>˅ƢȘʝʤʋKO ĸ 6H8 ĸʰƚȁʯʾˀʊƘƕɇ ¥ʕ·>ʜ˂

ʤĸʕ2ĸÞʿ˂ʤʋʚ˂ʿǬĸʰƑhèʓʾʳŏDŽƇƈǝĽ«˅ǹʧʤʕʊƑh èʓʾʳŏDŽƇƈǝʱàÈʝʮʔʧʤʋ

1-3. ALT10KO '1:D B+>/ AAL *3-.6

(

ɿ ALT10KOĸʰƚȁʱʊALT6ʬuŁʯǹʧʤʋPCRʓʾʳ˚˛̎Ȍİʯʾˀƚȁ ĸ10H36::G1ʓʾʳ10H36::G8ʕÞʿ˂ʤ (‰4)ʋALT10KOĸʓʾʳƚȁĸʰƑ hèĽ«ʰNJijʊKO ĸʊ10H36 ʯɐƇĸʫʹʿ˂ʤƑĖʱʹʿ˂ʮʔʧʤʋĚʊ ƚȁĸ10H36::G1ʓʾʳ10H36::G8ʱɐƇĸʬuƶʰƑĖʕʹʿ˂ʤ (‰5a)ʋŏ DŽƇƈǝĽ«˅ǹʧʤNJijʊɐƇĸʓʾʳƚȁĸʊ10H36::G1ʓʾʳ10H36::G8 ʫʱ™Ŋʕʹʿ˂ʤʋĚʊALT10KOĸʊ10H36ʫʱʊ?ʗ™Ŋʱʹʿ˂ʮʔʧʤ (‰5b)ʋHPLCȌİ˅ǹʧʤNJijʊɐƇĸʓʾʳƚȁĸʫʱʊAALŏDŽ˅ƣʟ˵̐

˔ʕĽJʜ˂ʤʋĚʊKOĸʊ10H36ʫʱʊAAL-TA˅ƣʟ˵̐˔ʱĽJʜ˂ʮʔ ʧʤʕĩƝʰ˵̐˔ʕĽJʜ˂ʤ (‰6a)ʋʚʰ˵̐˔ʱLC-MSȌİʰNJijʊ˪̉ː

̊˽̎ɍʰʮʐpentolamineʬuʰȩɑʕƣʜ˂ʤ (˩̐ˣʮʝ)ʋŏDŽɑʰ«ɑ ʯʾˀʊɐƇĸʫʱ26.0 µg/mlʊKOĸʊ10H36ʫʱ0 µg/mlʊƚȁĸʊ10H36::G1ʫ ʱ42.0 µg/mlʊ10H36::G8ʫʱ17.0 µg/mlʰŏDŽʕĽJʜ˂ʤ (ǽ9)ʋǬƿñɔŐ ȱ˅ǹʧʤʬʚ˃ʊPDA’ŽʫʱÅʱʹʿ˂ʠʊ˰ˊ˕̌˿ˊ˜̎BxĦ’Žʫʱʊ ɐèĸœʱñɔʯÅʱʹʿ˂ʮʔʧʤʋ˝ˌˮ˨ˉ˜̎xĦ’Žʫʱʊɐèĸʓ ʾʳKOĸʊ10H36ʯʓʐʪǬƿʰñɔʱʹʿ˂ʮʔʧʤʋƚȁĸʊ10H36::G1ʓ ʾʳ10H36::G8ʫʱǬƿʰñɔʯÅʱȇʿ˂ʮʔʧʤ (‰6b)ʋ

(35)

34

As-27 6H1 6H8 6H10

10

0 0 10 0 10 0 10

a

b

c

‰3ɿ ALT6KOĸʰƑhèĽ«ʊŏDŽƇƈǝĽ«ʓʾʳHPLCȌİ a; ALT6KOĸʰƑhèĽ«

b; ALT6KOĸʰŏDŽƇƈǝĽ«

c; ALT6KOĸʰHPLCȌİ

As-27; ɐèĸʊ6H1, 6H8; ALT6KOĸʊ6H10; 1˘˵̐KOĸ

(36)

35 ǽ8ɿ HPLCʯʾˁAALŏDŽʰ«ɑ

AAL-TA (µg/ml)

As-27 71.5 µg/ml 6H1 0 µg/ml 6H8 0 µg/ml 6H10 24 µg/ml HPLCȌİʯ“ʩʐʪAAL-TAʰ«ɑ˅ǹʧʤʋ

As-27; ɐèĸ

6H1, 6H8; ALT6KOĸ 6H10; 1˘˵̐KOĸ

(37)

36

a

b

c

‰4ɿ PCRʓʾʳ˚˛̎˷̌˦˨ˉ̎˕ʯʾˁALT10KOĸʬƚȁĸʰɆø a; PCRʯʾˁALT10KOĸʓʾʳƚȁĸʰɆø

homo; ƚuLjȴʹʯʾˀƇʞˁ˱̎˫

insert; ƚuLjȴʹʯʾˀhphːˠ˦˪ʬǕĉʜ˂ˁ˱̎˫

hph; ˰ˊ˕̌˿ˊ˜̎Bǚèɇ ¥ʰDɊɯ‘

npt; ˝ˌˮ˨ˉ˜̎ǚèɇ ¥ʰDɊɯ‘

b; ALT10KOĸʓʾʳƚȁĸʰ˚˛̎˷̌˦˨ˉ̎˕

˸̌̐˷; ALT10 insert

c; ALT10KOĸʓʾʳƚȁĸʰALT10ʰƒƃȌİ

Ǭ&˅4Ĝɖ’ɷÜʊRNA˅úJʝcDNAtñʝʤʋÞʿ˂ʤcDNA˅˨̎˸̋̐

˪ʯALT10ʰƒƃ˅RT-PCRʫƢȘʝʤʋ

As-27; ɐèĸʊ10H36; ALT10KOĸʊ10H36::G1, 10H36::G8; ALT10ƚȁĸ

(38)

37

a

b

‰5 ALT10KOĸʓʾʳƚȁĸʰƑhèʓʾʳŏDŽƇƈǝĽ«

a; ALT10KOĸʬƚȁĸʰƑhèĽ«

b; ALT10KOĸʓʾʳƚȁĸʰŏDŽƇƈǝĽ«

As-27; ɐèĸ 10H36; ALT10KOĸ

10H36::G1, 10H36::G8; ALT10ƚȁĸ

(39)

38

a

b

‰6 ALT10KOĸʓʾʳƚȁĸʰHPLCȌİʓʾʳǬƿñɔŐȱ

a; ALT10KOĸʬƚȁĸʰHPLCȌİ

ɥƜfʫƣʝʤ˵̐˔ʱALT10KOĸʰʹȇʿ˂ʤęȈʰ˵̐˔

b; ALT10KOĸʬƚȁĸʰǬƿñɔŐȱ

÷ƇżȩʰųÐʱ100 ppm As-27; ɐèĸ

10H36; ALT10KOĸ

10H36::G1, 10H36::G8; ALT10ƚȁĸ

(40)

39 ǽ9ɿ HPLCʯʾˁAAL-TAʰ«ɑ

AAL-TA (µg/ml)

As-27 26 µg/ml 10H36 0 µg/ml 10H3::G1 42 µg/ml 10H3::G8 17 µg/ml HPLCȌİʯʼʬʩʐʪAAL-TAʰ«ɑ˅ǹʧʤʋ

As-27; ɐèĸ 10H36; ALT10KOĸ

10H36::G1, 10H36::G8; ALT10ƚȁĸ

(41)

40

1-4-1. TRF1-4@@<=" KO'?!

ɿ CDCʯ§ʟˁ4ʨʰȯFȞƹɇ ¥ʊTRF1- TRF4ʰŅǝȌİ˅ǹʧʤʋʚ˂

ʿɇ ¥ʱʢ˂ʣ˂Zn(II)2Cys6ʰȯF†¥ (TRF1ʓʾʳTRF2)ʊC2H2 finger domain protein (TRF3) ʓʾʳC6 zinc finger domain containing protein (TRF4) ˅˘

̐˫ʝʪʐˁʬêʜ˂ʪʐˁʋPCR ʓʾʳ˚˛̎ȌİʰNJijʔʿʊTRF1 ʫʱʊ TRF1H5 ˅ KO ĸʬʝʊɘʰ¬ɹʯƉʐʤ (‰ 7)ʋuŁʯ TRF2 ʫʱʊTRF2H9 ʓʾʳ TRF2H45 ˅ KO ĸʬʝʊɘʰ¬ɹʯƉʐʤ (‰ 8)ʋuŁʯ TRF3 ʫʱʊ TRF3H2 ˅ KO ĸʬʝʊɘʰ¬ɹʯƉʐʤ (‰ 9)ʋʸʤʊuŁʯ TRF4 ʫʱʊ TRF4B4ʓʾʳTRF4D2˅KOĸʊTRF4A16˅˘˵̐KOĸʬʝʊɘʰ¬ɹʯ Ɖʐʤ (‰10)ʋ

1-4-2. TRF1-4@92 B+>HPLC;$ 0,;$

ɿ sǬĸ˅PDAʓʾʳV8’ŽʯļǬʝʊ1ȽɖÜʰǬʰÙî˅Ȋ³ʝʤʕʊɐè ĸʬ KOĸʯÅʱʹʿ˂ʮʔʧʤʋAALŏDŽʰ«ɑʰʤʻ HPLCȌİ˅ǹʧʤNJ ijʊTRF1-4ʰ?ʪʰǬĸʯʓʐʪAAL-TA˅ƣʟ˵̐˔ʕĽJʜ˂ʤ (‰7d) (‰ 8d) (‰9d) (‰10c)ʋTRF1H5ʯʓʐʪALT˔̈˞ˣ̐ɇ ¥ʰƒƃȌİ˅ǹʧʤ NJijʊɐèĸʾˀʼKO ĸʰĚʕʽʽƒƃɑʕ—ZʝʪʐʤʋʸʤʊALT1 ʯʓʐʪ KOĸʫʱĥ¸ʰ˱̎˫ʕĥʼƒƃɑʕʔʧʤ (‰11)ʋ

1-5-1. AVE1@<=" KO'?!

ɿ CDCʯ§ʟˁavenacinase˅˘̐˫ʝʪʐˁʬêʜ˂ʪʐˁAVE1ɇ ¥ʰŅ ǝȌİ˅ǹʧʤʋPCRʓʾʳ˚˛̎ȌİʰNJijʔʿAVH6˅KOĸʬʝʊɘʰ¬

ɹʯƉʐʤ (‰12a)ʋ

1-5-2. AVE1KO'/( 4(

ɿ ƑhèĽ«˅ǹʧʤʬʚ˃ʊɐèĸʬKOĸʯɲǯʮÅʱʹʿ˂ʮʔʧʤ (‰12b)ʋ ʸʤʊ˪˿˥̎ǚèĽ«˅ǹʧʤNJijʊɐèĸʓʾʳKO3ȁĸʰǜ¥ƒǪʯɲǯ ʮÅʱʹʿ˂ʮʔʧʤ (˩̐ˣŶʝ)ʋ

2. &7@)6;$

2-1-1. AaGPA1@<=" KO'?!

ɿ ÉĶǩ&ʯ§ʟˁ G protein 〈−subunit ˅˘̐˫ʟˁʬĆ«ʜ˂ˁɇ ¥ʊ

AaGPA1ʰŅǝȌİ˅ǹʧʤʋPCRʓʾʳ˚˛̎ȌİʰNJijʔʿ GPA1H1ʓʾʳ

GPA1H2˅KOĸʬʝʊɘʰ¬ɹʯƉʐʤ (‰13a)ʋ

(42)

41

TRF1H5 As-27

a b

c

d

‰7 PCRʬ˚˛̎˷̌˦˨ˉ̎˕ʯʾˁTRF1KOĸʰɆøʓʾʳHPLCȌİ a; PCRʯʾˁTRF1KOĸʰɆø

insert; ƚuLjȴʹʯʾˀhphːˠ˦˪ʬǕĉʜ˂ˁ˱̎˫

hph; ˰ˊ˕̌˿ˊ˜̎Bǚèɇ ¥ʰDɊɯ‘

exp; RNA˅úJʝcDNA˅tñÜʊTRF1ʰƒƃ˅RT-PCRʫƢȘʝʤʋ b; TRF1KOĸʰ˚˛̎˷̌˦˨ˉ̎˕ʊ˸̌̐˷; TRF1 A

c; TRF1KOĸʰ˚˛̎˷̌˦˨ˉ̎˕ʊ˸̌̐˷; TRF1 insert d; TRF1KOĸʰHPLCȌİ

As-27; ɐèĸʊ1H5; TRF1KOĸ

(43)

42

AAL-TA

As-27 2H9 2H45

a b

c

d

‰8ɿ PCRʬ˚˛̎˷̌˦˨ˉ̎˕ʯʾˁTRF2KOĸʰɆøʓʾʳHPLCȌİ a; PCRʯʾˁTRF2KOĸʰɆø

homo; ƚuLjȴʹʯʾˀƇʞˁ˱̎˫

insert; ƚuLjȴʹʯʾˀhphːˠ˦˪ʬǕĉʜ˂ˁ˱̎˫

hph; ˰ˊ˕̌˿ˊ˜̎Bǚèɇ ¥ʰDɊɯ‘

exp; RNA˅úJʝcDNA˅tñÜʊTRF2ʰƒƃ˅RT-PCRʫƢȘʝʤʋ b; TRF2KOĸʰ˚˛̎˷̌˦˨ˉ̎˕

˸̌̐˷; TRF2 B

c; TRF2KOĸʰ˚˛̎˷̌˦˨ˉ̎˕

˸̌̐˷; TRF2 insert d; TRF2KOĸʰHPLCȌİ ƜfʱAALŏDŽ˅ƣʟʋ

As-27; ɐèĸʊ2H9, 2H45; TRF2KOĸ

(44)

43

AAL-TA

As-27

3H2

5.8

3.5 5.8 (kb) As-27 3H2

As-27 3H2

a b

c d

‰9 PCRʬ˚˛̎˷̌˦˨ˉ̎˕ʯʾˁTRF3KOĸʰɆøʓʾʳHPLCȌİ a; PCRʯʾˁTRF3KOĸʰɆø

homo; ƚuLjȴʹʯʾˀƇʞˁ˱̎˫

insert; ƚuLjȴʹʯʾˀhphːˠ˦˪ʬǕĉʜ˂ˁ˱̎˫

hph; ˰ˊ˕̌˿ˊ˜̎Bǚèɇ ¥ʰDɊɯ‘

exp; RNA˅úJʝcDNA˅tñÜʊTRF3ʰƒƃ˅RT-PCRʫƢȘʝʤʋ b; TRF3KOĸʰ˚˛̎˷̌˦˨ˉ̎˕ʊ˸̌̐˷; TRF3 B

c; TRF3KOĸʰ˚˛̎˷̌˦˨ˉ̎˕ʊ˸̌̐˷; TRF3 insert d; TRF3KOĸʰHPLCȌİ

ƜfʱAALŏDŽ˅ƣʟʋ

As-27; ɐèĸʊ3H2; TRF3KOĸ

(45)

44

AAL-TA

A16 B4 D2

As-27

a

b c

‰10 PCRʬ˚˛̎˷̌˦˨ˉ̎˕ʯʾˁTRF4KOĸʰɆøʓʾʳHPLCȌİ a; PCRʯʾˁTRF4KOĸʰɆø

homo; ƚuLjȴʹʯʾˀƇʞˁ˱̎˫

insert; ƚuLjȴʹʯʾˀhphːˠ˦˪ʬǕĉʜ˂ˁ˱̎˫

hph; ˰ˊ˕̌˿ˊ˜̎Bǚèɇ ¥ʰDɊɯ‘

exp; RNA˅úJʝcDNA˅tñÜʊTRF4ʰƒƃ˅RT-PCRʫƢȘʝʤʋ b; TRF4KOĸʰ˚˛̎˷̌˦˨ˉ̎˕ʊ˸̌̐˷; TRF4 A

c; TRF4KOĸʰHPLCȌİ ƜfʱAALŏDŽ˅ƣʟʋ

As-27; ɐèĸʊB4, D2; TRF4KOĸʊA16; ˘˵̐KOĸ

(46)

45

As-27

TRF1H5

1 2 3 4 5 6 7 8 9 10 11 12 13 TF1H

(bp) 700 280 700 280

‰11ɿ TRF1KOĸʯʓʘˁALT˔̈˞ˣ̐ɇ ¥ʰƒƃȌİ

RNAʱ̉˥̄̐˟Ť&’Žʫ5Ĝɖāʬʑ’ɷʝʤǬ&ʔʿúJʝʊcDNAtñÜʊ ALT˔̈˞ˣ̐ɇ ¥ʰƒƃ˅RT-PCRʫƢȘʝʤʋ

As-27; ɐƇĸ TRF1H5; KOĸ

(47)

46

As-27 AVH6

a

b

‰12ɿ PCRʯʾˁAaAVE1KOĸʰɆøʓʾʳƑhèĽ«

a; PCRʯʾˁAaAVE1KOĸʰɆø homo; ƚuLjȴʹʯʾˀƇʞˁ˱̎˫

insert; ƚuLjȴʹʯʾˀhphːˠ˦˪ʬǕĉʜ˂ˁ˱̎˫

hph; ˰ˊ˕̌˿ˊ˜̎Bǚèɇ ¥ʰDɊɯ‘

exp; RNA˅úJʝcDNA˅tñÜʊAaAVE1ʰƒƃ˅RT-PCRʫƢȘʝʤʋ b; ƑhèĽ«

1ʀ1051/mlʯȞȂʝʤǜ¥ðŲŤ˅*Ɖʝʤʋ As-27; ɐèĸ

AVH6; AaAVE1KOĸ

(48)

47 (bp) homo

hph

insert

exp

839

356 409

356 As-27 GPA1H1GPA1H2

a

b

c

‰13ɿ PCRʯʾˁAaGPA1KOĸʰɆøʓʾʳƑhèĽ«

a; PCRʯʾˁAaGPA1KOĸʰɆø

homo; ƚuLjȴʹʯʾˀƇʞˁ˱̎˫ʊinsert; ƚuLjȴʹʯʾˀ hph ːˠ˦˪ʬǕĉ ʜ˂ˁ˱̎˫ʊhph; ˰ˊ˕̌˿ˊ˜̎Bǚèɇ ¥ʰDɊɯ‘

exp; RNA˅úJʝcDNA˅tñÜʊAaGPA1ʰƒƃ˅RT-PCRʫƢȘʝʤʋ b; ǬƿñɔŐȱ

c; ¬&ɲáɓʯʾˁǬʢʑʰŐȱ

As-27; ɐèĸʊGPAH1, GPAH2; AaGPA1KOĸ

(49)

48 2-1-2. AaGPA1KO''92 B+>

ɿ ǬƿñɔŐȱ˅ǹʧʤNJijʊɐƇĸʬŐȱʝʪ?ʪʰKOĸʫŒ ǬƿʕŨ¹ʝʊ Ǭʢʑʕ›_ʝʪʐʤ (‰ 13b)ʋʸʤʊǬƿʰȊ³˅ǹʧʤNJijʊɐèĸʫǜ¥ʰ Ƈƈʕȇʿ˂ˁĚʊKO ĸʊGPA1H1 ʓʾʳGPA1H2 ʫʱʶʬˆʭȇʿ˂ʮʔʧ ʤ (‰13c)ʋ

2-1-3. AaGPA1KO'/ AAL*3-.6(

ɿ ƑhèĽ«ʱǜ¥ʰ…lʕɢʝʔʧʤʤʻʊ˞˾˦˪ąƭʯʾˀǹʧʤʋɐèĸʫ ƑĖʕē1ȇʿ˂ˁĚʊKOĸGPA1H1ʓʾʳGPA1H2ʫʱƑĖʕűŨʝʪʐ ʤʋAAL ŏDŽƇƈǝĽ«˅ǹʧʤNJijʊɐƇĸʫʹʿ˂ˁ™ŊʕKO ĸGPA1H1 ʓʾʳGPA1H2ʫʱ—Zʝʪʐʤ (˩̐ˣŶʝ)ʋ

2-2-1. 8%/9 GPCRC

2-18*3+04 GPCR "()7% "

6GPCR&7-8NCBI12/$5 AaGPR1cAMP.GPCRAaGPCR2AaGPCR3carbon/amino!

#STE2Ste2!#'9

2-2-1. AaGPR1-3@<=" KO'?!

ɿ ÉĶǩ&ʯ§ʟˁG protein coupled receptor˅˘̐˫ʟˁʬĆ«ʜ˂ˁɇ ¥ʊ

AaGPR1-3ʰŅǝȌİ˅ǹʧʤʋAaGPR1ʫʱʊPCRʓʾʳ˚˛̎ȌİʰNJijʔʿ

GPR1N1 ʓʾʳ GPR1N2 ˅ KO ĸʬʝʊɘʰ¬ɹʯƉʐʤ (‰ 14)ʋuŁʯ AaGPR2ʫʱʊGPR2H1ʊGPR2H5ʓʾʳGPR2H8˅ KOĸʬʝʊɘʰ¬ɹʯƉ ʐʤ (‰15)ʋAaGPR3ʫʱʊGPR3H17˅KOĸʬʝʊɘʰ¬ɹʯƉʐʤ (‰16)ʋ

2-2-2. AaGPR1-3KO'92 B+> /(

ɿ sǬĸʰǬƿñɔ˅ŐȱʝʤʕʊɲǯʮÅʱʹʿ˂ʮʔʧʤ (‰ 17)ʋʸʤʊƑh èĽ«˅ǹʧʤNJijʊɐèĸʓʾʳKOĸʯɲǯʮÅʱʹʿ˂ʮʔʧʤ (‰18)ʋ

2-2-3. AaGPR3KO'1:D

ɿ AaGPR3KOĸʰƚȁʱʊALT6ʬuŁʯʝʪǹʧʤʋPCRʓʾʳ˚˛̎Ȍİʯʾˀ ƚȁĸGPR3H17::G1ʓʾʳGPR3H17::G16ʕÞʿ˂ʤʚʬʔʿɘʰ¬ɹʯƉʐ ʤ (‰16b, c)ʋ

(50)

49

a

b

‰14ɿ PCRʬ˚˛̎˷̌˦˨ˉ̎˕ʯʾˁAaGPR1KOĸʰɆø a; PCRʯʾˁAaGPR1KOĸʰɆø

homo; ƚuLjȴʹʯʾˀƇʞˁ˱̎˫

insert; ƚuLjȴʹʯʾˀnptːˠ˦˪ʬǕĉʜ˂ˁ˱̎˫

npt; ˝ˌˮ˨ˉ˜̎ǚèɇ ¥ʰDɊɯ‘

exp; RNA˅úJʝcDNA˅tñÜʊAaGPR1ʰƒƃ˅RT-PCRʫƢȘʝʤʋ b; AaGPR1KOĸʰ˚˛̎˷̌˦˨ˉ̎˕

˸̌̐˷; AaGPR1 insert As-27; ɐèĸ

GPR1N1ʓʾʳGPR1N2; AaGPR1KOĸ

(51)

50

(bp)

409

223 As-27

GPR2H1

GPR2H8

homo

hph insert

exp

223 1206 GPR2H5

a

b

c

‰15ɿ PCRʬ˚˛̎˷̌˦˨ˉ̎˕ʯʾˁAaGPR2KOĸʰɆø a; PCRʯʾˁAaGPR2KOĸʰɆø

homo; ƚuLjȴʹʯʾˀƇʞˁ˱̎˫

insert; ƚuLjȴʹʯʾˀhphːˠ˦˪ʬǕĉʜ˂ˁ˱̎˫

hph; ˰ˊ˕̌˿ˊ˜̎Bǚèɇ ¥ʰDɊɯ‘

exp; RNA˅úJʝcDNA˅tñÜʊAaGPR2ʰƒƃ˅RT-PCRʫƢȘʝʤʋ b; AaGPR2KOĸʰ˚˛̎˷̌˦˨ˉ̎˕

˸̌̐˷; AaGPR2 B

c; AaGPR2KOĸʰ˚˛̎˷̌˦˨ˉ̎˕

˸̌̐˷; AaGPR2 insert

As-27; ɐèĸʊGPR2H1ʊGPR2H5ʓʾʳ GPR2H8; AaGPR2KOĸ

(52)

51

a

b

c

‰16 PCRʯʾˁAaGPR3KOĸʰɆøʊƚȁĸʰ˛̎˷̌˦˨ˉ̎˕ʓʾʳƒƃȌ İ

a; PCRʯʾˁAaGPR3KOĸʰɆø homo; ƚuLjȴʹʯʾˀƇʞˁ˱̎˫

insert; ƚuLjȴʹʯʾˀhphːˠ˦˪ʬǕĉʜ˂ˁ˱̎˫

hph; ˰ˊ˕̌˿ˊ˜̎Bǚèɇ ¥ʰDɊɯ‘

exp; RNA˅úJʝcDNA˅tñÜʊAaGPR3ʰƒƃ˅RT-PCRʫƢȘʝʤʋ b; AaGPR3ƚȁĸʰ˚˛̎˷̌˦˨ˉ̎˕

˸̌̐˷; AaGPR3 insert

As-27; ɐèĸʊGPR3H17; AaGPR3KOĸ 3H17::G1, 3H17::G16; AaGPR3ƚȁĸ c; AaGPR3ƚȁĸʰƒƃȌİ

(53)

52

N1

N2 WT

WT H1

H5 H8

H17 WT

PDA V8

GPR1

GPR2

GPR3

‰17ɿ AaGPR1-3KOĸʯʓʘˁPDAʊV8ʓʾʳ̉˥̄̐˟’ŽʫʰÙîŐȱ a; PDAʓʾʳV8’ŽʫʰAaGPR1-3KOĸʰÙîŐȱ

sǬĸ˅ļǬ4ĜÜʯČÚʝʤʋ WT; As-27 (ɐƇĸ)

N1ʓʾʳN2; AaGPR1KOĸ H1ʊH5ʓʾʳH8; AaGPR2KOĸ H17; AaGPR3KOĸ

(54)

53

GPR1N1 GPR1N2

AAL-TA

GPR2H5 GPR2H8

GPR2H1 GPR3H17

‰18ɿ AaGPR1-3KOĸʰƑhèĽ«ʓʾʳHPLCȌİ

GPR1N1, GPR1N2; AaGPR1KOĸʊGPR2H1, GPR2H5, GPR2H8; AaGPR2KOĸ GPR3H17; AaGPR3KOĸ

(55)

54

2-2-4. AaGPR311:'5+> /(

ɿ ǜ¥Őȱ˅ǹʧʤNJijʊǜ¥ʰžʖʜʱɐƇĸʫʱ̏ 18 μmʊKO ĸʫʱ 15 μmʊƚȁĸʫʱ20 μmʥʧʤ (‰19a)ʋƑhèĽ«˅ǹʧʤNJijʊAaGPR3 KO ĸʯʓʐʪƑhXʰ%ʕȘʻʿ˂ʤ̒‰18̓ʋ

2-3. AaSTE2@<="92 B+> /(

ɿ ÉĶǩ&ʯ§ʟˁG protein coupled receptor˅˘̐˫ʟˁʬĆ«ʜ˂ˁɇ ¥ʊ

AaSTE2ʰŅǝȌİ˅ǹʧʤʋPCRʓʾʳ˚˛̎ȌİʰNJijʔʿ2ǬĸʰKOĸʕ

Þʿ˂ʤʋǬƿñɔŐȱʓʾʳƑhèĽ«˅ǹʧʤʬʚ˃ɐèĸʬ KO ĸʫɲǯʮ Åʱʹʿ˂ʮʔʧʤ (˩̐ˣŶʝ)ʋ

2-4-1. LAEA@<=" KO'?!

ÉĶǩ&ʯ§ʟˁ˳˞˪̎ʰmethyltransferase˅˘̐˫ʟˁʬĆ«ʜ˂ˁɇ ¥ʊ LaeAʰ˼̃̌˕ʕA. alternataʰsƑhʯġɀƕʯ§ʟˁʔʭʑʔ˅PCRʯʾ ʧʪƢȘʝʤʋʢʰNJijʊ?ʪʰƑhǬʫLaeA ʰ˼̃̌˕˅ƣʟ˱̎˫ʕĽJʜ

˂ʤʋǫĵƑǬʰ LaeA ˼̃̌˕ʫʏˁ AtLAEA ʰÙȩȯĉ˅ǹʧʤNJijʊ LAEAH40ʊLAEAH41 ʓʾʳ LAEAH43 ʰ KO ĸʕÞʿ˂ʤʋ̉̎˙ƑhǬʰ LaeA˼̃̌˕ʫʏˁAaLAEAʰÙȩȯĉ˅ǹʧʤNJijʊKOĸH13ʓʾʳH15ʕ Þʿ˂ʤʋˊ˥˙ƑhǬʰLaeA˼̃̌˕ʫʏˁAsLAEAʰÙȩȯĉ˅ǹʧʤNJijʊ KOĸH16ʊH20ʊH25ʕÞʿ˂ʤʋ

2-4-2. AtLAEAKO '92 B+>5-.6+>9A+>/

AAL*3-.6(

ɿ Ǭƿñɔ˅ŐȱʝʤNJijʊKOĸʊLAEAH40ʊLAEAH41ʓʾʳLAEAH43ʫʱ ɐèĸʫʹʿ˂ʤŒ ǬƿʕűŨʝʪʐʤ (‰20)ʋǜ¥ƇƈǝŐȱʓʾʳƑh èĽ«˅ǹʧʤNJijʊKOĸʫʱʊɐƇĸʫʹʿ˂ʤǜ¥ʓʾʳƑĖʕűŨʝʪʐ ʤ (‰21)ʋʸʤʊŏDŽƇƈǝĽ«˅ǹʧʤNJijʊKOĸʫʱɐèĸʫʹʿ˂ʤ™Ŋ ĖʕűŨʝʪʐʤ (‰22a)ʋHPLCȌİ˅ǹʧʤNJijʊ?ʪʰǬĸʯʓʐʪAAL ŏDŽ˅ƣʟ˵̐˔ʕĽJʜ˂ʤ (‰22b)ʋŏDŽɑʰ«ɑʯʾˀʊɐƇĸʫʱ16.1 µg/mlʊKOĸʊLAEAH40ʊLAEAH41ʓʾʳLAEAH43ʫʱʢ˂ʣ˂1 µg/mlʊ1.1 µg/mlʓʾʳ1.2 µg/mlʰŏDŽʕĽJʜ˂ʤ (ǽ10)ʋǬ&ɑ˅ŐȱʝʤNJijʊKO ĸʱɐèĸǬ&ɑʰǁ2/3ƬÐʯŨ¹ʝʪʐʤ (‰22c)ʋ

(56)

55

a

b

‰19ɿ AaGPR3KOĸʓʾʳƚȁĸʰǜ¥ñɔ a; AaGPR3KOĸʓʾʳƚȁĸʯʓʘˁǜ¥

V8’Žʫ2Ƚɖ’ɷʝʊǜ¥˅…lʝʤʋ b; AaGPR3KOĸʓʾʳƚȁĸʯʓʘˁǜ¥ɔ a, b, cʯʱʢ˂ʣ˂ĦëÅʕȘʻʿ˂ʤʋ As-27; ɐèĸ

3H17; AaGPR3KOĸ

3H17::G1ʓʾʳ3H17::G17; AaGPR3ƚȁĸ

(57)

56

‰20ɿ AtLAEAKOĸʰǬƿñɔ As-27; ɐƇĸ

LAEAH40ʊLAEAH41ʓʾʳ LAEAH43; AaLAEAKOĸ PDAʫ’ɷÜ5ĜƘʯČÚʝʤʋɿ

(58)

57

5#

a

b

c

‰21ɿ AtLAEAKOĸʰÙîʊǜ¥ƇƈǝʓʾʳƑhèĽ«

a; AtLAEAKOĸʰ¬&ɲáɓʯʾˀȊ³ʝʤKOĸʰǬʢʑ b; AtLAEAKOĸʰ˸̋̐˪1IJʏʤˀʰǜ¥ēŐȱ

c; AtLAEAKOĸʰƑhèĽ«

As-27; ɐƇĸʊLAEAH40, LAEAH41, LAEAH43; AaLAEAKOĸ

(59)

58 AAL-TA

LaeAH40 LaeAH41 LaeAH43

AAL-TA

As-27

AAL-TA

10

0 0 10 0 10 0 10

a

b

c

‰22ɿ AtLAEAKOĸʰŏDŽƇƈǝĽ«ʊHPLCȌİʓʾʳǬ&ɑ a; AtLAEAKOĸʰŏDŽƇƈǝĽ«

b; AtLAEAKOĸʰHPLCȌİ c; AtLAEAKOĸʰǬ&ɑ

̉˥̄̐˟Ť&’Žʫ2Ƚɖ’ɷÜʊźʜʡɏɑ˅ū«ʝʤʋ

As-27; ɐƇĸʊLAEAH40ʊLAEAH41ʓʾʳ LAEAH43; AaLAEAKOĸ

(60)

59 ǽ10ɿ HPLCʯʾˁAALŏDŽʰ«ɑ

4, AAL-TA (µg/ml)

As-27 16.2 µg/ml

LAEAH40 1 µg/ml

LAEAH41 1.1 µg/ml

LAEAH43 1.2 µg/ml

AALŏDŽʰ«ɑʱHPLCʯ“ʩʐʪǹʧʤʋ As-27; ɐƇĸ

LAEAH40ʊLAEAH41ʓʾʳ LAEAH43; AaLAEAKOĸ

(61)

60

2-4-3. AtLAEAKO''@0,;$

ɿ RNA˅úJʝʊɇ ¥ʰƒƃȌİ˅ǹʧʤʬʚ˃ʊKOĸʫʱALT˔̈˞ˣ̐ɇ

¥ ʰ ƒ ƃ ɑ ʕ ɐ è ĸ ʾ ˀ ʼ Ũ ¹ ʝ ʪ ʐ ʤ ʋ Ě ʊ ˔ ̈ ˞ ˣ ̐ D ʯ §  ʟ ˁ metalloproteaseɇ ¥ʱɐèĸʬKOĸʫƒƃɑʯ›_ʱʮʔʧʤ (‰23a)ʋʸʤʊ ƒƃɑʰnj´ɑ˅Őȱʝʤʬʚ˃ʊɐèĸʫɺʔʧʤ˔̈˞ˣ̐ɇ ¥ʰƒƃʕKO ĸʫŨ¹ʝʪʐʤʋALT˔̈˞ˣ̐œʰɇ ¥ʱɐèĸʓʾʳKOĸʫƒƃɑʕ

¹ʮʔʧʤ (‰23b)ʋÉĶǩ&ʯ§ʟˁɇ ¥ʰƒƃȌİ˅ǹʧʤNJijʊKOĸ ʰƒƃɑʱɐèĸʰƒƃɑʬŐȱʝʪAKSʫʱ72ʊVKSʱǁ32ʯ—Zʝʪʐ ʤʋMAT1 ʓʾʳ ALMʫʱƒƃɑʯɲǯʮÅʱʹʿ˂ʮʔʧʤʋɐèĸʫʱ 4 ɇ ¥ʰƒƃɑ?ʪʕβ-tublinʬŐȱʝʪ¹ʮʔʧʤ (‰24)ʋ

2-4-4. AaLAEA AsLAEAKO'92 B+>/ AAL

*3-.6(

ɿ ǬƿñɔŐȱ˅ǹʧʤNJijʊAaLAEAʓʾʳAsLAEAKOĸʬʼʯʊɐèĸʫʱʹ ʿ˂ʤŒ Ǭƿʕʶʬˆʭʹʿ˂ʮʔʧʤ (‰ 25)ʋHPLC Ȍİ˅ǹʧʤNJijʊ?ʪ ʰǬĸʯʓʐʪŏDŽ˅ƣʟ˵̐˔ʕĽJʜ˂ʤ (‰ 26)ʋƑhèĽ«ʓʾʳŏDŽƇ ƈǝĽ«˅ǹʧʤNJijAsLAEAKOĸʫʱʊɐèĸʫʹʿ˂ˁƑĖʓʾʳ™ŊĖʱ ʶʬˆʭʹʿ˂ʮʔʧʤ (‰27)ʋ

(62)

61

a

b

‰23ɿ AtLAEAKOĸʓʾʳɐƇĸʯʓʘˁCDCɇ ¥ʰŐȱƒƃȌİ

Ȫ; ALT˔̈˞ˣ̐ɇ ¥ ɽǩ; ȯFȞƹ†¥

ɥ; ȑœʰɇ ¥ a; ɐƇĸʬʰƚ´4

sɇ ¥ƒƃʱʂ-tublinɇ ¥˅1ʬʝʪʸʠē4_ʝʤʋ

ɐƇĸʫÞʿ˂ʤē4˅1ʬʝʪKOĸʰƒƃɑ˅˕̈˶ʯƣʝʪʐˁʋ b; ƒƃɑʰnj´4

ʂ-tublinɇ ¥˅1ʬʝʤğʰƒƃɑ

(63)

62

a

b

‰24ɿ AtLAEAKOĸʰÉĶǩ&ɇ ¥ʰƒƃȌİ

̉˥̄̐˟’Žʫāʬʑ’ɷ8ĜÜʰǬ&ʔʿRNA˅úJʝʊcDNA ˅tñÜʊ̉ˈ

̊ˣˊ́PCRʯʾʧʪƒƃɑ˅«ɑʝʤʋ

a; ʂ-tublinɇ ¥ʓʾʳɐèĸʰsɇ ¥ƒƃ˅1ʬʝʤ•tʰAtLAEAKOĸɇ ¥ʰɐƇĸʬʰƚ´4

b; ʂ-tublinɇ ¥˅1ʬʝʤ•tʰsɇ ¥ʰƒƃɑʰnj´4 ɽ: As-27; ɐèĸ

ɥ: H40; AtLAEAKOĸ

(64)

63

a

b

‰25ɿ A. alternatả̎˙Ƒhʓʾʳˊ˥˙ƑhʰLaeAKOĸ (AaLAEAKOĸ ʓʾʳAsLAEAKOĸ) ʰǬƿñɔ

a; AaLAEAKOĸʰǬƿñɔ

PDAʯļǬÜʊ5ĜƘʯČÚʝʤʋ IFO8984; ̉̎˙ĖŵǭǮƑǬ H3ʓʾʳH5; AaLAEAKOĸ b; AsLAEAKOĸʰǬƿñɔ PDAʯļǬÜʊ5ĜƘʯČÚʝʤʋ NAF8; ˊ˥˙ɾĖƑǬ

H16ʊH20ʓʾʳH25; AsLAEAKOĸ

(65)

64

a ɿɿ

b

‰26ɿ A. alternatả̎˙Ƒhʓʾʳˊ˥˙ƑhʰLaeAKOĸ (AaLAEAKOĸ ʓʾʳAsLAEAKOĸ) ʰHPLCȌİ

a; AaLAEAKOĸʰHPLCȌİ IFO8984; ̉̎˙ĖŵǭǮƑǬ H3ʓʾʳH5; AaLAEAKOĸ b; AsLAEAKOĸʰHPLCȌİ NAF8; ˊ˥˙ɾĖƑǬ

H16ʊH20ʓʾʳH25; AsLAEAKOĸ

(66)

65

‰27ɿ AsLAEAKOĸʰƑhèĽ«ʓʾʳŏDŽƇƈǝĽ«

Ǯʱínèˊ˥˙ƭƖÁ16r˅*Ɖʝʤʋ NAF8; ˊ˥˙ɾĖƑǬ

H16ʊH20ʓʾʳH25; AsLAEAKOĸ

; ƑhèĽ«

1ʀ1051/mlʯȞȂʝʤǜ¥ðŲŤ˅*Ɖʝʤʋ ; ŏDŽƇƈǝĽ«

(67)

66 Ƶ

Ƶ4ƹɿ Ǚ³

ɿ ŇʌʯƓ•ʟˁę˜̐˔ˍ̎˚̐ʰƒ½ʯʾˀʊžɑʰ˗˯́é”ʕDZƮʜ˂

ʨʨʏˁʋǬɳʯʓʐʪʼAspergillus¾ʽNeurospora crassaʓʾʳˊˮʐʼʦƑǬ Magnaporthe griseaʮʭʗʰǬʯʨʐʪ˗˯́ȌİʕLJʝʤ (Dean et al. 2005, Galagan et al. 2003, Galagan et al. 2005, Machida et al. 2005)ʋĥȵʫʱʊʚ˂ʿ˗˯

́ʰŐȱȌİʕǹ˄˂ʊǬɳʯʓʘˁȾ_ʽK_ʮʭ˅ǏǖƕʯȌİʟˁʚʬʕ qǝʬʮˀʨʨʏˁ (Gao et al. 2011, Ma et al. 2010, Amselem et al. 2011)ʋ˗˯́?

&˅QƉʝʤŐȱȌİʱʊǬĸɖʫʰƚuɯ‘ʊʏˁʐʱȯÑʽžʖʮ˩̉̐˜̇

̎ʮʭ˅ȇJʟ•tʯɨÉʯĦ\ʫʏˁʋʢʰʤʻʊƑhèǬʕÿʨɇ ƕŽâ ʮʭ˅ȇJʟʚʬʕqǝʫʏˁʋĚʊʗʰ•tʊɨÉʯȵǔʰǬĸɖʫʜʒʊʢ ʰ˗˯́ŀñʱƏʮˁʤʻʊ1ʌʰɇ ¥ʕʭʑʐʧʤŅǝ˅ʝʪʐˁʔʱʊʢ˂ʣ

˂ʰɇ ¥ʯʨʐʪɇ ¥ơ™ʽ˚ˊ̋̎˜̎˕ʮʭ˅ʟˁäȅʕʏˁʋ

ɿ A. alternataʱʊʚ˂ʸʫʯ¹ʮʗʬʼ7ʨʰƑhʕ”zʜ˂ʪʓˀʊʢ˂ʣ˂Ə ʮˁ°ŽƏƕŏDŽ (HST) ˅ƇƈʟˁʚʬʕƝʿ˂ʪʐˁʋʸʤʊ7Ƒhʰʑʦˣ

˱˘˅ʰʣʗƑhʫHSTƇƈʯɗʟˁɇ ¥ʕcɡʊu«ʜ˂ʪʐˁ (Aakagi et al. 2009, Akamatsu et al. 2003, Miyamoto et al. 2009, Tanaka et al. 1999, 2000, Hatta et al. 2002, Ruswandi et al. 2005, Johnson et al. 2000, 2001, Harimoto et al.

2007)ʋ˪˿˪ʊ̉̎˙ʓʾʳˊ˥˙ʰ 3 Ƒhʯʓʐʪʱʊʚ˂ʿɇ ¥ʕ˔̈˞ˣ̐

_ʝʪʓˀʊʔʨƇ§ʯʱäɮʫʱʮʐĶǩ&ʫʏˁ conditionally dispensable chromosome (CDC) ʯÑʝʪʐˁʚʬʕ”zʜ˂ʪʐˁ (Akagi et al. 2009, Harimoto et al 2007, Hatta et al. 2002)ʋ

ɿ sƑhʕ.ĦʟˁHSTƇtñɇ ¥ʱʊʶʬˆʭʰ•tʊʰHSTƇtñɇ ¥ʬƚuèʕʮʗʊǫĵƑǬʫȇJʜ˂ʤ 13 ʰ AAL ŏDŽƇtñɇ ¥ (ALT ɇ ¥) ʰ˼̃̌˕ʱʊʰ A. alternata ʯʓʐʪʱȇJʜ˂ʪʐʮʐʋĚʫʊ essential chromosome (EC) ʰɇ ¥ʱƏʮˁƑhɖʫʼɨÉʯɺʐƚuèʕ Șʻʿ˂ʪʐˁ (Kusaba et al. 1995. Akagi et al. 2009)ʋ…ʰ¬ɹʫʊǫĵƑǬʔ ʿÞʤLaeAʰ˼̃̌˕ʊAtLAEAʰɋM˅“ʯ)Ȃʝʤ˸̈ˊ˿̐˅*ƉʝʤɞʊĽ

«ʝʤ?ʪʰƑhʫƘƕʰ˱̎˫ʕĽJʜ˂ʤʚʬʔʿʼʊCDC œʰɇ ¥ʱ ɨÉʯƚuèʕɺʐʚʬʕʑʔʕʒˁʋʚʰʾʑʯʊƑhèA. alternataʱʊɺÐʯ.

§ʜ˂ʤ EC ʬʊʬʪʼ̆˭̐˔ʮɋMʊʟʮ˄ʦ HST Ƈtñɇ ¥ʕÑʟˁ CDC ˅.ÿʝʤĿʻʪŽâƕʮ˗˯́ŀȻ˅ĦʝʪʐˁʬʰǙʒʕʜ˂£ʻʪʐ ˁʋ

ɿ A. alternata ʱʚ˂ʸʫʰƠưʫʊɇ ¥ˣ̐˗˦˨ˉ̎˕Řʕŀƻʜ˂ʪʓˀʊŃ

参照

関連したドキュメント

It is suggested by our method that most of the quadratic algebras for all St¨ ackel equivalence classes of 3D second order quantum superintegrable systems on conformally flat

pole placement, condition number, perturbation theory, Jordan form, explicit formulas, Cauchy matrix, Vandermonde matrix, stabilization, feedback gain, distance to

In particular, we consider a reverse Lee decomposition for the deformation gra- dient and we choose an appropriate state space in which one of the variables, characterizing the

Next, we prove bounds for the dimensions of p-adic MLV-spaces in Section 3, assuming results in Section 4, and make a conjecture about a special element in the motivic Galois group

Transirico, “Second order elliptic equations in weighted Sobolev spaces on unbounded domains,” Rendiconti della Accademia Nazionale delle Scienze detta dei XL.. Memorie di

Then it follows immediately from a suitable version of “Hensel’s Lemma” [cf., e.g., the argument of [4], Lemma 2.1] that S may be obtained, as the notation suggests, as the m A

In order to be able to apply the Cartan–K¨ ahler theorem to prove existence of solutions in the real-analytic category, one needs a stronger result than Proposition 2.3; one needs

We provide an efficient formula for the colored Jones function of the simplest hyperbolic non-2-bridge knot, and using this formula, we provide numerical evidence for the